Wharton

MBA Program in Health Care Management

2021 RESUME BOOK Contents Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-31 Internship Sponsors ...... 31 Health Care Program Mentors ...... 32 Administration ...... 33 Faculty ...... 34-35

Thank you for your interest in the Wharton MBA Program in Health Care Management . For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 email: csavoie@wharton .upenn edu.

For information on the Wharton Health Care Management Alumni Association, visit www .whartonhealthcare .org

For detailed information on the Health Care Management Department educational programs, visit http://mba .wharton .upenn .edu/healthcare 2021 Health Care Management

MBA Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740 . Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution . As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education . Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine . The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874 . The world’s first psychological clinic was opened at Penn in 1896 .

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management . Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education . In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education .

Today, the Wharton School has more than 480 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research . The 1,785 students in the master’s degree program may choose from among more than 200 courses and over 19 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual .

This brochure is provided to introduce you to the 2021 Wharton Health Care Management Program graduates .

We encourage you to consider these individuals for employment .

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time 2-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School . The program, the principal and delivery of health care . Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students insurance, managed care, hospitals, corporations, interested in the health care management field . pharmaceutical companies, and other health- By combining the skills of the Wharton disciplines related organizations . Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery private health insurance in the United States . He of health services and products at all levels . was the founder of Colonial Penn Group, Inc ,. a company that has pioneered in insurance for older The Program has produced graduates who have Americans . Both Mr . Davis and Mrs . Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute . entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government . Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations .

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management International Programs: Core . The Wharton School’s core curriculum is designed to Global Modular Courses: Short full-credit courses in an intensive increase crossfunctional integration, extend global experience, workshop format in a country relevant to the topic . strengthen leadership training, and introduce new courses on key management issues . The core curriculum provides ground- Global Immersion Program (GIP): work in basic management disciplines: economics, A high-level survey of the economic, cultural, and geo-political finance, financial and cost accounting, management science, drivers behind regions integral to the global economy . Students managing people and organizational design, marketing, then experience it in-country . operations management, the governmental and legal environment of business, statistics, and strategy . The Health Care Major Courses and Electives: These courses promote an understanding of concepts, Fixed Core: institutions, and issues involved in the organization, • Leadership: Foundations of Teamwork and Leadership financing, and delivery of health services and products • Marketing: Marketing Management in the United States . Health care electives are selected • Microeconomics: Microeconomic Foundation consistent with individual career objectives and interests . • Economics: Advanced Topics in Managerial Economics • Statistics: Regression Analysis for Managers Required • Management Communication: Speaking and Writing • Health Services System • Health Care Field Application Project Flexible Core: Operations, Information, and Decisions Electives • Quality and Productivity • Comparative Health Care Systems • Business Analytics • E-Health: Business Models and Impact • Information Technology and Business Transformation • Financial Management of Health Institutions • Innovation • Healthcare Data & Analytics • Operations Strategy • Health Care Entrepreneurship • American Health Care System: Policy, Politics and Reform Marketing • Health Care Services Delivery: • Dynamic Marketing Strategy A Managerial Economic Approach • Strategic Marketing Simulations • US Payer Provider Strategy • Management & Economics of Pharmaceutical & Communications Biotechnology Industries • Advanced Persuasive Speaking • Management and Strategy in Medical Devices • Communications Challenges for Entrepreneurs and Technology • Management of Health Care for the Elderly Accounting • Management of Health Care Service Businesses • Financial Accounting • Managing Health Care Organizations • Accelerated Financial Accounting • Private Sector Development in Global • Financial and Managerial Accounting Health Development • Advanced Study Project Corporate Finance • Corporate Finance The Health Care Summer Internship • Accelerated Corporate Finance The internship is a 3-month management experience that • Introduction to Corporate Finance provides the health care major an opportunity to work with a senior executive in an organization of particular interest to Macroeconomics the student . • Macroeconomics • Introduction to Macroeconomics MBA Electives Opportunities are available for the health care major to pursue Management a second concentration in fields such as entrepreneurship, • Managing the Established Enterprise marketing, finance, or operations, or to pursue specialized • Managing the Emerging Enterprise knowledge in areas such as health care financing or within specialized segments of the health care industry including Legal Studies & Business Ethics managed care organizations, hospitals, pharmaceutical and • Responsibility in Global Management biotechnology companies, medical device companies, specialty • Responsibility in Business services organizations, and long term care organizations . Graduate courses are available throughout the University .

5 Monica Adibe Emily P. Arfman Chiaka N. Aribeana [email protected] [email protected] [email protected] Stanford University, Stanford, CA Northwestern University, Evanston, IL Harvard University, Cambridge, MA B .A ., Human Biology and Political Science, 2013 B S. ., Cum Laude, Biomedical Engineering, 2015 A .B ., Molecular and Cellular Biology, 2012 Stanford University School of Medicine, Stanford, CA M .D . Candidate, 2021

An opportunity to build technology An opportunity to build a new technology- An opportunity to combine my clinical enabled healthcare products that enabled care delivery business that and management training to improve address social determinants of health. provides underserved populations health care delivery through innovation. with improved access to high quality, Facebook, Menlo Park, CA affordable, whole-person healthcare. Stanford Hospitals and Clinics, Product Marketing Manager MBA Intern Stanford, CA Summer 2020 7wireVentures, Chicago, IL Clinical Clerkship in Department of Pediatrics Developed segmentation and product Summer Associate, Summer 2020 and Department of Radiology strategy to activate a new type of pub- Sourced and assessed early stage Worked with physicians in the Department lic entity on the platform . digital health companies for seed and of Pediatrics and Department of Radiology series A investments out of a $100M to provide patient care during the COVID Doximity, San Francisco, CA fund . Completed industry and business pandemic . Treated patients in the Pediatric Manager, Strategic Analytics, 2016-2019 diligence within the behavioral health ICU and developed patient care plans . Collaborated with product, data, and and care delivery space . Developed Made appropriate diagnoses by inter- sales leadership to develop client- thought leadership for strategic lim- preting full-body magnetic resonance facing tools to accelerate the sales ited partners and for external health- imaging studies and developed treatment development process . Developed go- care publications, with a focus on the plans for cancer patients based on clinical to-market opportunity assessment and effect of COVID-19 on digital health . judgment and evidence-based protocols . recommendation that was accepted by Stanford University School of Medicine, the Chief Commercial Officer . Advised Oxeon Ventures & Eleanor Health, Stanford, CA 80-person commercial team on best New York, NY Clinical Rotations 2017–2019 practices for using data-driven sales Strategy & Operations Lead, 2019 Coordinated with doctors and medical materials in new business development . Developed clinical services model for comprehensive treatment of patients team to develop care plans for patients and provided direct patient care . Oliver Wyman, Washington, D.C. with substance use disorder . Led operational readiness for launch of Completed inpatient and outpatient Consultant ,2014-2016 rotations at Stanford Hospital and first de novo clinic, including workflow Completed readiness assessment of Clinics and affiliated Bay Area hospitals . design, staffing, and technology a $2 .4B healthcare corporation’s Rotations included: Internal Medicine, requirements . Developed partnership preparedness to transition to a value- General Surgery, Neurosurgery, OBGYN, models with payers and complementary based healthcare model . Devised strat- Family Medicine, Psychiatry, Emergency egy for a Fortune 100 insurance carrier providers to accelerate growth . Medicine, Cardiology, Neurology, to triple revenue in energy vertical; plan Interventional Radiology . Conducted was adopted into company roadmap . Deloitte Consulting, New York, NY research with the Chair of the Consultant, 2017-2019 Department of Cardiothoracic Surgery Mercer, Washington, D.C. Analyst, 2015-2017 and published research in peer-reviewed Government Consulting Analyst, 2013-2014 Advised healthcare payers, providers, medical and scientific journals . Developed strategy to bolster outreach medical technology companies, and and enrollment in Medicaid in the U S. . pharmaceutical companies on digital Cardinal Free Clinics, Palo Alto, CA Virgin Islands, resulting in expedited and innovation strategies . Led the devel- Cardiology Clinical Manager at Arbor Clinic Medicaid enrollment for nearly 4K opment of a new technology venture 2015-2016 additional residents . Improved New within a leading Medicare Advantage Managed the Cardiology Specialty Clinic Mexico’s oversight of its health insur- payer that secured $10M in external at Arbor Free Clinic . Coordinated care ance companies, including overhauling venture capital investment . for uninsured patients in Stanford the state’s reporting tools and training Hospital Cardiology Department and 20 state Medicaid workers to use the scheduled cardiology appointments at new tools . Arbor Free Clinic . Oversaw general clinic operations, including scheduling physicians and clinic providers, monitoring patient appointment flow, and optimizing logistics to maximize efficiency .

6 Graham M. Attipoe Brett R. Baker Ibrahim Bengali [email protected] [email protected] [email protected] Duke University, Durham, NC Washington University in St . Louis, St . Louis, MO Northwestern University, Evanston, IL B .S ,. Biology, 2017 B S. ., Valedictorian, Biomedical Engineering, 2011 B .S ., Industrial Engineering, 2014 Vanderbilt University School of Medicine, Nashville, TN M .D . Candidate, 2022

An opportunity to strategize the improve- Solve difficult problems for leading An opportunity to leverage the latest ment of health care delivery through healthcare companies—developing consumer technology to improve advancing innovation, developing medical myself and others along the way. people’s lives, especially their mental technologies, and partnering with the and physical health. companies that will define the future. Sanofi Pasteur, Swiftwater, PA Management Associate Program Intern, Facebook, Menlo Park, CA Windham Venture Partners, Summer 2020 Product Strategy Intern, Summer 2020 New York, NY Managed COVID-19 response taskforce Proposed 3 large product solutions to MBA Associate, Summer 2020 for North America marketed products . build over next 3-5 years in the growing Sourced and conducted due diligence to Responsibilities spanned collection and online services space, after assessing evaluate series seed to B stage startups analysis of customer insights, managing products across Facebook’s Family of in the medical technology and digital development of above-brand marketing Apps and identifying critical gaps at health sectors . Presented industry, strategies, and returning salesforce the Facebook Inc level business, and financial diligence analysis (remotely) to the field . to investment committee with focus on clinical applications Boston Consulting Group, Boston, MA Oliver Wyman, Chicago, IL Consultant 2017-2019 Associate, Health & Life Sciences, 2014-2019 Boston Consulting Group, Seattle, WA Associate 2015-2017 Led collaborative development of Summer Consultant, Summer 2020 Consulted companies in strategic and $200-500M strategy projects and their Operated as a Social Impact Ambassador operational topics across a variety of initial implementation with payers and for BCG as a function of my summer industries and functional areas . providers in the transition to value- MBA internship . Developed a roadmap Selected experience includes: Data based care, new front doors, county- for the repurposing of FDA-approved strategy formation for a medical level products and new technology drugs in rare and orphan diseases . device manufacturer, Integration solutions . Management Office for merger Tennessee Titans, Nashville, TN between two clinical trial services/ Ta’leef Collective, Chicago, IL Administrative Assistant, 2017-2018 technology companies, Human Staff Member, 2013-2019 Managed schedule and appearances of Resources integration for R&D business Managed volunteers at 200+ annual the Tennessee Titans Football entertain- unit in top-10 pharma merger, market events, with audiences up to 600; ment team and mascot . Coordinated scan / due diligence for a major con- Grew team from 3 to 40+, resulting halftime shows and fan engagement tract research organization (CRO), in 5,000+ volunteer hours, $125,000 initiatives . Represented organization platform strategy development for payroll savings and justifying Board to in a public relations role at charity, technology company’s AI asset, authorize full-time Chicago campus educational, and private events diagnostic technology assessment to with annual ~$1M budget . Provided identify investment opportunities for coaching and preliminary counseling, a non-profit organization . triaging to licensed mental health professionals or spiritual guides MGH & BWH Center for Clinical Data Science, Boston, MA Product Manager (BCG Externship) 2017-2018 Managed and deployed 2 radiology artificial intelligence software products across business case proposal, require- ments gathering, software development, and implementation . Led team of 6 soft- ware developers to direct development .

7 Benjamin S. Berman Karlos D. Bledsoe J. Logan Brock [email protected] [email protected] [email protected] Tufts University, Medford, MA Princeton University, Princeton, NJ University of Colorado, Boulder, CO B .A ., Political Science, 2015 A .B ,. Ecology and Evolutionary Biology, 2015 B .A ., Summa Cum Laude, Neuroscience, 2016 Penn Law, Philadelphia, PA Perelman School of Medicine at the University J .D . Candidate, 2021 of Pennsylvania, Philadelphia, PA M .D . Candidate, 2020

An opportunity to build and scale an An opportunity to partner with an An opportunity to combine clinical, innovative healthcare company from emerging team investing in early-stage scientific, and business knowledge to the ground up, focused on the direct healthcare innovation including exposure improve health care through policy and to consumer pharmaceutical space. metabolic and/or rare diseases. novel therapeutics.

Amazon, Seattle, WA PRINCO, Princeton, NJ RTW Investments, LP, New York, NY Senior Product Manager, Summer 2020 Summer Associate Intern, Summer 2020 Research Intern, Summer/Fall 2020 Developed business case, user stories, Diligence of venture and buyout Conducted investment diligence of requirements, and business rules for managers including team evaluation, small- and mid-cap biotechnology change in Amazon operations projected performance analyses, and investment companies for a health care investment to lead to $420M in yearly savings by decisions . Participated in reference fund . Evaluated potential disease 2023 . Led working group including calls, assessed co-investment opportu- indications and therapeutic regimens software developers, machine learning nities, modeled returns waterfalls, and to support portfolio companies’ pipeline experts, and operational program voted in capital commitment decisions . strategies . Assessed an in-licensing managers to stand up solution . opportunity in the cardiovascular Trinity, Boston, MA market for a portfolio company . Deloitte Consulting, New York, NY Consultant, 2015-2018 Consultant, 2016–2019 Addressed strategic commercial questions McKinsey & Company, Chicago, IL Designed and executed strategy for for biopharmaceutical companies across Summer Associate, Summer 2020 large-scale pharma patient services company stages and therapeutic areas . Developed a safe return-to-work transformation; Orchestrated work- Conducted indication prioritization strategy for an employer of ~10,000 stream operations for 2 specialty drugs work, forecasting, and go-to-market with an emphasis on COVID-19 testing . representing $4B annual sales, from strategy . Combined financial, regulatory, Performed cost and volume modeling design to launch of patient support epidemiological, and KOL inputs to of COVID-19 tests to evaluate potential programs (co-pay, adherence, Hub generate models which informed both employee safety paradigms . services) . Independently led standup internal client decisions and external Communicated overall safe return of patient support services for pharma M&A activity . Led project work streams strategy to senior leadership and patient mobile application, including and managed junior team members . entire North American workforce . brand new contact center (telephony sys- tem, agent training, KPI adherence, etc .) . Longitude Capital, Menlo Park, CA Research Fellow, Fall 2019 Mainely Burgers, Portland, ME Analyzed the shift to value-based Co-Founder, 2011 - 2014 health care payments models and Founded gourmet food truck company developed investment theses high- servicing greater Portland area (3 lighting four promising new models, trucks, 16 employees); 150% revenue culminating in Longitude leading a growth from year 1 to year 2 . $64M investment in a company Successfully lobbied City Council for operating in the space . food truck law . Featured on Food Network’s Eat St .; Winner, Eater’s “Maine’s Best Burger;” Winner, 2013 Portland “Entreverge” Award .

8 Ross H. Brown Catherine A. Bryt James C.S. Buxton, [email protected] [email protected] M.D. Dartmouth College, Hanover, NH Dartmouth College, Hanover, NH A .B ., Magna Cum Laude, Government, 2014 B A. ,. Cum Laude, Economics & Neuroscience, 2015 [email protected] University College London, London, UK B .Sc . Medical Science with Surgical Sciences, 1st Class, Dean’s List, 2011 M .D ., Medicine, 2014

An opportunity to improve people’s An opportunity to lead healthcare An opportunity to invest in, build and health and well-being through innovative, payment innovation to increase lead companies bringing revolutionary cost-effective strategies. system efficiency while giving patients therapeutics to patients. the power and incentive to choose Accolade, Philadelphia, PA affordable care. Morgan Stanley, London, UK Senior Manager – Strategy & Corporate Summer Associate, Summer 2020 Development, Fall 2020 Sibi Health, Philadelphia, PA Sourced, analyzed and presented biotech Corporate Strategy Intern, Summer 2020 Founder and CEO, 2020-Present targets for strategic acquirers and Supported corporate development Launched Sibi Health, a membership- sponsors in line with long-term team’s analysis and execution of based platform for patients to book therapeutic and modality areas of multi-year business strategy, including and purchase healthcare services interest . Performed a range of valuation potential partnerships and acquisitions . directly from providers . Recruited and analyses of a large French pharma Developed strategic recommendations managed team of 12 . Built and scaled client . Produced a critical analysis of for new product offering and presented proprietary network of providers and the EU healthcare IT landscape in light to senior leadership . hosted financial transactions . of COVID-19 tail and headwinds . Developed channel partnerships for Deloitte Consulting, Washington, DC efficient distribution and revenue . New Rhein Healthcare Investors, Senior Consultant, 2018-2019 Philadelphia, PA Consultant, 2016-2018 Brighton Health Plan Solutions, Consultant, 2020 Business Analyst, 2014-2016 New York, NY Consultant on a due diligence for a Led and supported teams that developed Chief of Staff to the CEO and CFO, series B investment in a medical device improvement strategies for senior lead- 2018-2019 company . Provided a critical assessment ers at five federal health agencies, Partnered with C-Suite and external of competitor products, FDA submission including the Military Health System advisors to plan for spinoff and sale cadence and comparative trial design . (MHS), the Department of Veterans of business lines . Led SWAT team of Presented findings leading to a $5M Affairs (VA), and the Department of department heads to close deals with investment . Health and Human Services, among key business partners, establish strategy others . Sample projects included: and draft contracts . Managed forecasting, Imperial NHS Trust designing pilot to address appointment budgeting, sales compensation and Surgical Trainee, 2017-2019 wait time crisis at the VA and advising Board communications . Progressed through rotations in Commanding Officers of military Cardiothoracic and Plastic Surgery hospitals how to improve quality of and MM.LaFleur, New York, NY completing over 300 operations . access to care in MHS’ largest market . Senior Associate, Strategy, Analytics and Ranked in the top 2% of candidates Beyond client work, assessed viability FP&A 2017-2018 during national selection for training of several potential internal product Associate, Strategy, Analytics and FP&A positions . Completed and presented offerings and one potential acquisition, 2016-2017 research on peri-operative reduction and made investment recommendations Analyst, Customer Experience 2015-2016 of opioid use and prediction of post- to firm leadership . Also managed team Joined as 15th employee, helping grow operative complications . to develop internal communications for revenue 1,000% to 200+ employees 2,000+ practitioners . through Series A & B led by Meritech, Bessemer & Thrive Capital . Responsible for company’s revenue targeting and alignment of management around tar- gets . Delivered actionable insights and developed company-wide reporting and data standardization by managing a cross-functional team of department heads and engineering .

9 Frank F. Cai Cody W. Carpenter Sandy Cheung [email protected] [email protected] [email protected] Duke University, Durham, NC University of California San Diego, La Jolla, CA Northwestern University, Evanston, IL B .S ,. Magna Cum Laude, Evolutionary Biology, Ph .D ., Nanoengineering, 2019 B .A ., Biological Sciences and Economics, 2015 2015 M S. ., Nanoengineering, 2014 B S. ., Nanoengineering, 2013

An opportunity to improve the patient An opportunity to combine scientific An opportunity to support and provide experience using technological innovation, expertise and business acumen to strategic recommendations for health strategic thinking, and operational advance personalized medicine. services and biopharma companies excellence. seeking to improve patient outcomes Eli Lilly, Indianapolis, IN through innovative technology and Boston Consulting Group, Summit, NJ MBA Intern, Accelerated R&D Leadership novel therapies. Summer Consultant, Summer 2020 Program, Summer 2020 Advised a large healthcare provider on Led cross-functional team of 9 in a Credit Suisse, New York, NY commercialization strategy within two virtual environment to define company’s Investment Banking Summer Associate, product groups: one COVID-19 long-term strategy for a therapeutic Summer 2020 “Return to Work” product and a area . Secured $150K in funding and Advised health services, biopharma and concierge medicine service . Worked onboarded new team lead to implement medical devices companies on various in conjunction with client marketing strategic vision . Presented findings and financial transactions including an IPO, team to develop a revamped sales recommendation to a panel of senior capital raise, and sell-side M&A process strategy to attract new customers in leaders including the Chief Scientific by utilizing various valuation method- a virtual setting while supporting Officer and Chief Medical Officer . ologies and strategic assessments . “Go-Live” operations for COVID-19 “Return to Work” initiative for large University of California San Diego, Accenture, Chicago, IL employers in NYC La Jolla, CA Consultant, 2018-2019 Ph.D. candidate in the Lipomi Research Analyst, 2016-2018 Accenture, New York, NY Group Advised leading healthcare systems on Strategy and Consulting Manager, Pioneered new field of research com- operations strategy and technology 2015-2019 bining techniques in nanofabrication transformations . Analyzed investment Worked with large payer and provider and behavioral psychology (co-authored opportunities in digital technologies and clients to optimize clinical operations 14 publications over entire academic advanced analytics that will drive growth and performance . Frequently conducted career) . Led interdepartmental team and operational improvements for vari- quantitative field studies and analysis of four graduate students to develop ous health services companies . Identified of productivity data to decrease a stroke rehabilitation device using areas for improvement on hospital EMR patient length of stay and generate augmented reality and haptic systems that will better workflow and cost savings . Select experience also feedback . care coordination . Led workstreams for included implementation of a new hospital post-merger integration . care management operating model for Arytha Biosciences, LLC., an 11-hospital health system and created Sorrento Valley, CA a patient portal serving 80k+ patients Scientist (Employee #1) for a large provider in the Midwest . Built out Arytha Biosciences’ first operational lab, established supplier FrontDoor, New York, NY & vendor networks and negotiated Product and Operations Lead, 2018 $500K in purchases . Led scale-up Developed product roadmap and user development of biologic formulation stories for initial fall detector prototype and demonstrated technology to customized for nursing and long-term investors, helping secure $6M Series care facilities . A funding round ($30M valuation) .

10 Michele Dragoescu Jillian D. Zhang Chuka T. Esiobu [email protected] [email protected] [email protected] Stanford University, Stanford, CA Dartmouth College, Hanover, NH Harvard University, Cambridge, MA B .S ,. Materials Science & Engineering, 2012 A .B ., Neuroscience, 2013 A .B ., Cum Laude, Neurobiology, 2020

An opportunity to generate and execute An opportunity to accelerate the An opportunity to invest in and support commercial strategies that bring novel development and commercialization the expansion of innovative healthcare therapeutics to patients in need. of life sciences innovations to improve technology companies. patient outcomes through a commercial Pfizer Inc. New York, NY strategy or business development role. Define Ventures, San Francisco, CA Pharmaceutical Marketing Summer MBA Intern, Summer 2020 Associate, Summer 2020 Pfizer Inc., New York, NY Supported sourcing and diligence Developed global strategy for market Pharmaceutical Marketing Summer efforts for VC deals across the digital expansion for rare disease product on Associate, Summer 2020 health landscape . Created investment track for blockbuster status . Presented Supported the Commercial team with memo for a successful deal and was to commercial leadership on regionally the launch of a rare disease product in granted investment committee voting customizable strategic recommendations Emerging Markets . Led the development rights . Developed investment theses for expansion to new physician and implementation of internal tools to and spearheaded company incubation groups . Identified content creation help marketers across 14 countries efforts . opportunities based on patient journey improve disease awareness and diagnosis and brand strategy and managed rates . Collaborated with cross-functional Bessemer Venture Partners, Boston, MA relationship with creative agency to teams to deliver strategic and tactical Associate Intern, 2019–2020 develop new promotional assets . plans for 6 priority markets . Supported deal processes for early and growth-stage companies and developed Bolt Threads, Portland, OR Artisan Healthcare Consulting, theses to guide future healthcare Corporate Responsibility Manager, 2018-2019 Waltham, MA investments . Co-authored a published Marketing Manager, 2016-2018 Team Leader 2018-2019 roadmap titled, “Drugs in a Virtual Marketing Associate, 2015-2016 Senior Consultant 2016-2018 World: The Rise of Digital Health Served as launch manager for company’s Consultant, 2015-2016 Solutions in Clinical Trials” . first three product launches, resulting Associate, 2013-2015 in over 50,000 website views and Biopharma consultant leading com- Evolent Health, Arlington, VA products selling out in hours . Managed mercial strategy projects, including Associate Director, 2018–2019 cross-functional strategy and execution portfolio prioritization, opportunity Senior Analyst, 2018-2018 of multi-channel digital marketing analysis, forecasting and launch plan- Managed cross-functional teams, com- campaigns and press coverage, including ning . Provided project oversight and prised of data scientists and physicians, a CEO presentation and product coaching across multiple concurrent to lead strategic development and launch at SXSW . Helped to secure projects and served as client contact implementation of new value-based care alliance with Patagonia, Inc . by for 20+ clients . Managed projects gen- initiatives . Program focus areas included serving as technical liaison to business erating $1M+ and sourced new busi- bundled payments, elective surgeries, development partners and presenting ness leads, resulting in $400,000 specialty referral optimization, and clinical research on genetic engineering . annually . Project highlights: (1) Led decision support . Led clinical diligence team in determining differentiation efforts for ~20 Accountable Care Bolt Threads, Emeryville, CA drivers for oncology products and Organizations (ACOs) and co-developed Molecular Biology Research Associate facilitated 15 cross-functional differen- business case for three closed M&A deals . 2012-2015 tiation workshops; (2) Designed clinical Automated high-throughput research development plan for new oncology The Boston Consulting Group, District and development experiments with treatment to drive commercial value, of Colombia recombinant silk genes and proteins . leveraging primary research, revenue Associate, 2016–2018 Founded yeast strain screening pipeline forecast and NPV; (3) Analyzed longi- Partnered with clients across healthcare, and increased speed and throughput tudinal claims data for 6M+ patients to technology, and public sectors . by automating experimental steps and drive go-to-market strategy for new Restructured advocacy approach for data analysis asthma product . a large biopharmaceutical company during drug launch .

11 Tiffany K. Fan Haley H. Fitzpatrick J. Alex Flick [email protected] [email protected] [email protected] Yale University, New Haven, CT Stanford University, Stanford, CA Boston College, Chestnut Hill, MA B .A ., Economics, 2014 B S. ., Biology, 2015 B .S ., Summa Cum Laude, Management, 2013 John . F . Kennedy School of Government at Harvard University, Cambridge, MA M .P .P . Candidate, 2021

An opportunity to improve healthcare An opportunity to help bring break- An opportunity to build and invest in delivery in order to impact patient through therapies to patient populations innovative healthcare companies. outcomes and quality of care. with unmet need by being a commercial leader at a pharmaceutical or biotechnology Lee Equity Partners, New York, NY UCLA Health, Los Angeles, CA company. Private Equity MBA Intern, Summer 2020 Administrative Intern, Operations Evaluated investments in various Summer 2020 Genentech, South San Francisco, CA healthcare services verticals and Developed forward-looking business Commercial Summer Associate, supported closing of Solaris Health, model for ambulatory surgery service Summer 2020 a urology physician practice manage- line . Collaborated with cross-functional Led strategy, planning and execution ment platform . Completed initial due team to implement prioritization algo- for virtual Advisory Board to generate diligence on 3 add-on acquisitions for rithm in transfer center workflow and insights that will inform key tactics for Solaris Health and partnered with electronic medical record system . line extension launch for respiratory executive team to implement post- Created intensive care unit staffing product . Spearheaded design and closing, strategic initiatives . Presented factbase to inform flex requirements as planning for virtual launch meeting thesis for home health / hospice sector, result of COVID-19 pandemic . and field training, collaborating with leading to bids on 2 businesses . commercial leaders, training, produc- Received an offer to return full-time Boston Consulting Group, tion vendor, and co-promote partners as a Vice President . Washington DC amidst uncertainties of new company Consultant, 2016-2017, 2018 field structure . Consonance Capital Partners, Seconded, 2017-2018 New York, NY Associate, 2014-2016 Health Advances, San Francisco, CA Private Equity Senior Associate, 2017-2019 Partnered with clients across healthcare, Consultant, 2018-2019 Private Equity Associate, 2015-2017 social impact, and other industries on Senior Analyst, 2016-20 Member of 10-person team managing strategy and operations projects . Led Analyst, 2015-2016 a $500M healthcare private equity cross-functional team across 4 academic Team leader at life sciences strategy fund . Engaged in end-to-end deal medical centers to develop behavioral consulting firm overseeing project exe- process for 5 closed transactions, therapy program . Analyzed and cution, acting as primary client contact deploying over $200M of equity in a launched new benefit offering focused and managing up 10 analysts across variety of healthcare service verticals . on small business and non-profit concurrent projects . Completed over 30 Performed all facets of investment customers of national pharmacy bene- projects in diverse therapeutic areas evaluation: thesis generation, sourcing, fits manager . Worked with global and specialized in client engagements due diligence and valuation . pharmaceutical companies to improve focused on commercialization and go- Supported senior management team supply chain management for 6 key to-market strategy, in-licensing asset of 3 portfolio companies in strategic medications . Executed Bloomberg identification, portfolio planning, life- and capital structure decisions . Philanthropies’ Mayors Challenge as cycle management, launch planning, secondee . due diligence and competitive assess- Jefferies LLC, New York, NY ment . Project highlights: 1) Managed Investment Banking Analyst, Healthcare, 6-member team to conduct quantita- 2013-2015 tive market research and develop Executed 2 M&A, 2 debt and 5 equity 7-year revenue forecast to quantify transactions in a variety of healthcare impact of competitor drug launch in verticals representing over $1 .3B in hemophilia 2) Led 4-member team to transaction value . Focused on health- create excel-based asset evaluation tool care services transactions, including with 400+ clinical-stage assets priori- specialty pharmacy (Injured Workers tized for in-licensing or acquisition to Pharmacy) and post-acute care (Envoy guide neurology portfolio expansion Health Care) .

12 Michael J. Gawlik Victoria B. Gentry Joshua R. Gertsman [email protected] [email protected] [email protected] University of Southern California, Vanderbilt University, Nashville, TN Carleton University, Ottawa, ON Los Angeles, CA B A. ., with Honors, Magna Cum Laude, B .Comm ., High Distinction, Finance and B .S ,. Cum Laude, Accounting, 2011 Medicine, Health, and Society, 2015 Accounting, 2015

An opportunity to invest in, partner An opportunity to improve access to and An opportunity to translate scientific with, and build leading healthcare quality of healthcare for all, through discoveries into new medicines that can services and technology companies. improvements and innovations in care improve human health delivery and healthcare outcomes. Grant Avenue Capital, New York, NY Aditum Bio, Oakland, CA MBA Intern, Summer 2020 Mount Sinai Health Partners, MBA Investment Associate, Summer 2020 Led business and commercial diligence New York, NY Member of investment team of newly- for the acquisition of a provider of home Commercialization Team Intern, raised biotech venture fund focused health and hospice services, ultimately Summer 2020 on in-licensing and developing individual leading to the signing of a new platform Researched COVID-19 data and guide- therapeutics across a broad range of investment for the first-time fund . lines and advised 10+ clients on how disease areas and modalities . Identified to safely return to the workplace . opportunities and performed scientific, WindRose Health Investors, Developed content for “COVID-19 operational and financial due dili- New York, NY Consult” offering to improve patient gence of potential targets . Led devel- Associate, 2016-2019 access to current information . opment of bottoms-up (patient build) Evaluated and executed private equity operating and valuation model used investments across a wide range of Veteran and First Responder Healthcare, to facilitate asset evaluation, transaction healthcare sub-sectors as part of a New York, NY structuring and assessment of financial team of 12 investment professionals Strategy Associate, Summer 2020 returns . managing ~$1 .2B of capital . Completed Analyzed data and advised on growth two platform acquisitions: 1) a provider strategy to expand mental telehealth Dyal Co, New York, NY of physician-led clinical documentation and substance abuse treatment ser- M&A Associate, 2018-2019 improvement services to hospital vices for Veterans and First M&A Analyst, 2017-2018 customers and 2) a provider of analytics- Responders . Focused on transformative M&A, activ- driven marketing services to the ism defense and pipeline bolt-ons for pharmaceutical space . Managed and Deloitte Consulting, Arlington, VA large BioPharma clients . Executed 4 executed add-on M&A for several Consultant, 2017-2019 M&A transactions representing over portfolio companies across the health- Analyst, 2015-2017 $100B in transaction value including care landscape include fertility, payor Designed and developed VA Office of Bristol-Myers Squibb’s acquisition of services/capitated risk models, substance Women’s Health Services training Celgene, Novartis’ acquisition of AveXis abuse, and consumer payment sub- curriculum for Active Duty Servicewomen . and Novartis’ consumer JV with GSK . sectors . Conducted pilot program and evaluated curriculum at 6 military installations BMO Capital Markets, Toronto, ON Jefferies, New York, NY to determine course efficacy, which Investment Banking Analyst, 2016-2017 Analyst, 2014-2016 ultimately led to VA and DoD approval Member of the Mergers & Acquisitions Conducted financial analyses and due for implementation of the course at team . Performed financial analyses diligence on mergers and acquisitions military installations across the country and due diligence on mergers and advisory assignments for clients across by 2021 . Provided pro bono consulting acquisitions for companies across a the healthcare services and life sciences services to the Veteran Employment Task diversified range of industries . industries . Executed over $4B of transac- Force, managing 40-50 representatives Completed transactions representing tion value across 4 M&A, 1 debt financ- from the White House, federal agencies, over $40B in transaction value . ing and 2 equity financing transactions . and industry to develop and imple- ment Veteran employment solutions .

13 Poorwa Godbole Radhika Gupta Alexander F. Halikias, [email protected] [email protected] FSA Stanford University, Stanford, CA Columbia University, New York, NY B .A ., Economics, 2016 B A. ,. Economics, 2016 [email protected] Binghamton University, Binghamton, NY B .S ., Summa Cum Laude, Economics, B .A ., Summa Cum Laude, Mathematics, 2015

An opportunity to lead within a mission- An opportunity to design, develop and An opportunity to innovative in health driven organization developing and implement programs that promote care and drive improved outcomes at scaling innovative healthcare delivery health in our communities. lower costs. solutions to improve access to and quality of care. Oshi Health, New York, NY Bind Health, Minneapolis, MN Strategy and Operations Intern, MBA Intern, Corporate Development and McKinsey & Company, San Francisco, CA Summer 2020 Product Management, Summer 2020 Summer Associate, Summer 2020 Conducted hiring for providers and Developed member-level quantitative Advised regional health system on developed payer strategy to support model to evaluate Individual Coverage physician alignment strategy to launch of virtual specialty clinic for a HRA Legislation and evaluated strategic strengthen relationships with doctors seed stage startup . paths . Assisted in Go-to-Market efforts in the community and improve quality for new product launch, including sales and continuity of care for local Humana, Louisville, KY & operations process integration . patients . Operationalized McKinsey’s Corporate Strategy Intern, Summer 2020 Crafted data privacy design principles internal COVID-19 response strategy Developed value proposition and out- and mapped to consumer segmentation . and safety policies . lined economics for prospective deal between health system and care delivery Cigna, Bloomfield, CT Gates Ventures, Seattle, WA organization . Designed unified consumer Actuarial Advisor, Government Businesses, Health and Life Sciences Program Analyst, platform and performed high-level 2018-2019 2018-2019 M&A assessment . Defined scaling Actuarial Senior Specialist, Health Care Developed online tools, white papers opportunities for primary care clinics . Reform, 2018 and presentations for Mr . Gates on Actuarial Specialist, Health Care Reform, topics in healthcare and Alzheimer’s Pfizer, New York, NY 2017-2018 Disease . Oversaw content creation, Manager, 2018-2019 Actuarial Senior Analyst, Pricing, 2015-2017 graphic design and web development Managed global cross-functional Evaluated end to end risk optimization of interactive online platform for teams to optimize Phase III trials for process, including AI models, ROI, healthcare education . Supported exe- vaccine candidates . Assessed financials efficiency, and opportunities . Created cution of grants, gifts and other instru- for $5B+ vaccine and rare disease models for 2020 ACA market expansion ments in line with the office’s portfolios to obtain R&D funding . analysis to rank and evaluate viability of Alzheimer’s philanthropy strategy . Collaborated with asset teams to new geographies . Assessed legislative address potential supply shortages . changes in health insurance to determine McKinsey & Company, San Francisco, CA Created financial tools to assess and feasibility of new products and delivered Business Analyst, 2016-2018 prioritize $10M+ capital investments in strategic recommendations to senior Focused on healthcare systems and supply chain . leadership . Developed an agent-based services practice . Project highlights: (1) microsimulation to predict consumer Designed and implemented scorecard health care buying decisions and used it for measuring access and patient satis- PwC Strategy&, New York, NY to quantify pricing impacts of proposed faction at primary care outpatient clinics Associate, 2016-2018 legislation – i .e . 10% rate increase attrib- at large West Coast health system (2) Developed strategic plan to consolidate uted to removal of individual mandate . Improved patient access, experience, regional IT platforms onto unified Led cross-functional teams to shape sup- safety and quality of outpatient clinics platform, impacting 11M members . plemental/voluntary/individual product at major metropolitan community Designed care management program strategy . Owned pricing for Mental health system (3) Redefined payor nego- to reduce high cost care for high risk Health/Substance Abuse, Autism, tiation strategy and operating model for patients and developed associated and EAP . large non-profit health system . business case . Led workshops and collaborated with hospital and payer teams to design patient experience for new joint ventures .

14 Sneha Hariharan Kyle D. Herman Joshua I. Ho [email protected] [email protected] [email protected] Anna University, Chennai, India University of Virginia, Charlottesville, VA University of California—Berkeley, Berkeley, CA Bachelor of Technology, Gold Medalist, B S. ., Commerce, B .A . Foreign Affairs, 2014 B .A ., Integrative Biology & Social Welfare, 2015 Pharmaceutical Technology, 2011 Perelman School of Medicine at the University Penn State University, State College, PA of Pennsylvania, Philadelphia PA M .S ., Molecular, Cellular and Integrative M .D . Candidate, 2021 Biosciences, 2016

An opportunity to integrate my An opportunity to invest in, partner with, An opportunity to leverage clinical scientific background with business and build leading healthcare services and experience to build and scale technology- experience to improve public access to technology companies. enabled healthcare that improves access pharmaceutical products without and outcomes. compromising innovation. Optum, Remote OLE Grad Intern, Summer 2020 W Health Ventures, Boston, MA SANOFI PASTEUR, Swiftwater, PA Co-led new product development ini- Investment/New Ventures Intern, Summer Intern, Management Associate tiative around hospital-at-home, pivot- Summer 2020 Program, Summer 2020 ing to other in-home care initiatives . Led thesis development and landscape Defined 2021 annual strategic impera- Received offer to return as an associ- of remote patient monitoring market, tives to grow administration of pediat- ate principal . resulting in conceptualization and ric vaccine portfolio in the wake of the pitch of new venture . Supported deal pandemic . Designed core messaging NaviMed Capital, Washington, D.C. process for virtual care delivery resulting content for portfolio and liaised with Associate, 2017 - 2019 in 1 successful deal . regulatory counterparts to ensure Evaluated and executed private equity compliance . investments across healthcare, payor Centre for Infectious Disease Research in and pharmaceutical services and tech- Zambia, Lusaka, Zambia PALL CORPORATION, Westborough, MA nology as part of a team of 6 invest- Corrections Health Fellow, Summer 2017 Field Application Scientist, 2018-2019 ment professionals managing ~$115M Managed survey pilot for cost analysis Led operational support for over 20 of capital . Completed three platform of HIV care model in prison system . bio-pharmaceutical clients; delivered investments, and one add-one acquisi- Evaluated substance use and mental process improvement solutions for labo- tion leading deal processes on lean health provider landscape to create ratory and manufacturing scale filtration teams . Managed several portfolio partnerships and care protocols for needs . While there, also spearheaded companies, attending board meetings, releasees transitioning out of prison . direct-to-consumer marketing efforts monitoring performance, and driving Re-designed exit interview using visual by planning and presenting technical/ strategic and operational initiatives . tools to improve services . regulatory webinars on application of microbiology product line in food The Advisory Board Company, YouthTruth Survey, San Francisco, CA safety and expanded siloed low-reve- Washington, D.C. Product/Research Fellow, 2015-2016 nue product into a 4-product line by Associate, 2016 – 2017 Managed product development and maximizing existing manufacturing Assessed, modeled, and diligenced 20+ market launch of two surveys to capabilities to better reflect customer growth stage healthcare acquisition expand suite of school feedback needs identified by conjoint analysis . opportunities, with focus on tech- offerings, with national reach of over enabled solutions . Collaborated with 200,000 participants . Directed survey RUBIUS THERAPEUTICS, Cambridge, MA 15+ senior executives creating a new research and validation, pilot, data Sr. Research Associate, 2017-2018 digital health marketing tool analysis, product iteration, and Research Associate, 2016-2017 technical integration and roadmap . Developed quality improvement strat- Guggenheim Securities, New York, NY egies for flagship products and part- Analyst, 2014 - 2016 nered with cross-functional team of 15 Conducted financial analyses and due members . In addition, pioneered 100X diligence on mergers and acquisitions scaleup of flagship therapeutic tech- advisory assignments for clients across nology by liaising between R&D and the technology, media, and telecom manufacturing and performed finan- sectors . Executed two M&A transac- cial forecasting on in-house novel tions during tenure . gene delivery project .

15 Vivien L. Ho Philip D. Holsted Kelly Hsu [email protected] [email protected] [email protected] Northwestern University, Evanston, IL Northwestern University, Evanston, IL Yale University, New Haven, CT B .S ,. Industrial Engineering and B A. ,. Magna Cum Laude, Economics and B .A ., Magna Cum Laude, Biology and Management, 2016 Psychology, 2015 Economics, 2015

An opportunity to drive change in the An opportunity to improve global health An opportunity to improve healthcare healthcare system by investing in inno- equity and access through strategy and access and outcomes by building and vative healthcare technology companies. operations. supporting innovative, value-based healthcare organizations. Pear VC, Palo Alto, PA Genentech, San Francisco, CA Summer VC Associate, Summer 2020 Commercial Summer Associate, Oxeon Venture Studio, New York, NY Spent summer working closely with Summer 2020 MBA Intern, Summer 2020 Founding Managing Partner across Simplified patient initiation by design- Pitched, researched and wrote a tear sourcing, first meetings, diligences and ing a pilot program for at-home blood sheet for a novel company, leading to supporting portfolio companies as a tests, including selection of pilot loca- conversations with potential investors . board observer . Supported diligence tions, collection of patient input, and process in successful pre-seed/seed evaluation of vendors . Improved physi- Eleanor Health, Boston, MA investments across digital health and cian experience when prescribing Product Intern, Summer 2020 future of work . Partnered with accelerator Venclexta by creating order set instruc- Defined scope and deliverables for a companies to build 0 to 1 strategy and tions and an accompanying training dashboard that reflects a member’s business plan in Pear Summer across for field rollout . recovery status and progress . women’s health, supply chain logistics, Developed partnerships with social AI/ML enterprise software tools and McKinsey & Company, Chicago, IL determinants referral networks, which future of work . Senior Business Analyst, 2018-2019 led to 3 signed contracts . Business Analyst, 2015-2017 Airbnb, San Francisco, CA Projects include: (1) Prioritized future Bill and Melinda Gates Foundation, Strategy & Analytics Associate, 2018-2019 vaccines for client organization to pur- Seattle, WA Supported the CFO and Homes Busines sue based on potential lives saved and Associate Strategy Officer, 2018-2019 Lead on monthly business reviews, market attractiveness . (2) Developed Prioritized grants by impact and board reviews, and company-wide new corporate strategy for leading drafted launch plans for prioritized initiatives . Worked on various cross- residential real estate company . (3) products: outlined strategies for functional strategy projects for Homes Drove $25M in savings for a consumer manufacturer selection, defined and Transportation leadership such as goods company by identifying interre- regulatory approach and identified building new mobility product strategy, lated opportunities across assortment, financing channels . Stood up 3 developing more efficient paid marketing research and development, and design investment committees to execute plans . plan and identifying opportunities in for manufacturability . new strategic geographies . McKinsey & Company, New York, NY Bill and Melinda Gates Foundation, Engagement Manager, 2018 Boston Consulting Group, Chicago, IL Seattle, WA Senior Business Analyst, 2017 Consultant 2020-2020 Associate Strategy Officer (Secondee), Business Analyst, 2015-2017 Associate, 2016-2019 2017-2018 Served healthcare, technology and Advised clients across Healthcare, Led a 7-person working group to social sector clients on a range of stra- Consumer & Tech across M&A and design, cost, and prioritize funding tegic and operational topics . A high- corporate development, growth and support scenarios worth up to $800M lighted selection includes defining commercial strategy and white space market entry strategy into digital innovation . Project highlights: (1) for polio vaccines in 87 countries . health for a Fortune 500 retailer, Operational excellence program for Coordinated activities across 5 global building donor funding strategies for pharma manufacturing company (2) public health organizations to develop a global public health nonprofit, iden- Cell therapy commercial model for a transition strategy to maintain polio tifying process improvement initiatives global pharma (3) Online-to-offline eradication and bolster country health for a healthcare agency’s redesign and digital marketing and app loyalty systems after poliovirus is eliminated . supporting payors on growth and strategy for global internet services company (4) Provider growth and care product strategy . delivery strategy for Medicare payer .

16 Victoria M. Huang Anna C. Irving Ulysses C. Isidro [email protected] [email protected] [email protected] University of Chicago, Chicago, IL Rutgers University, New Brunswick, NJ Yale College, New Haven, CT B .A ., Biology, 2015 B A. ., Summa Cum Laude, Ethics, Economics and B .S ., Distinction, Molecular, Cellular, and Politics, 2014 Developmental Biology (Intensive), 2015 Yale School of Public Health, New Haven, CT M .P .H ., Health Care Management and Global Health, 2016 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2021

An opportunity to build and grow a An opportunity to shape access into An opportunity to integrate clinical mission-driven healthcare or technology a seamless, consumer-centric and knowledge, business experience, and company. cost-conscious patient experience. health policy research to improve the overall value of health care and enhance PicnicHealth, San Francisco, CA Morgan Stanley, New York, NY patients’ lives. Commercial Intern, Chief of Staff to the Investment Banking Summer Associate, CEO, Summer/Fall 2020 Summer 2020 Arterys, San Francisco, CA Worked directly with C-suite on key Engaged in summer programming and Product Strategy Intern, Summer 2020 strategic initiatives . Led cross-func- simulated projects to advise a multi- Developed go-to-market strategy, con- tional team to standardize delivery of billion dollar luxury goods client on ducted customer segmentation analysis, real-world evidence to life science valuation, potential M&A, and LBO and initiated strategic partnerships for a partners . Spearheaded re-launch of scenarios Series C radiology artificial intelligence patient referrals product . startup . Clinton Health Access Initiative, Sanofi, Cambridge, MA Mbabane, Eswatini Penn Medicine Department of Digital Catalyst Senior Manager 2018–2019, Global Finance Associate, 2019 Radiology, Philadelphia, PA Manager 2018 Strategized go-forward vision and devel- Research Assistant, 2019-Present Sourced, vetted, and partnered with oped cost models and implementation Conduct and publish industry analysis innovative digital health startups in plan to achieve malaria elimination in on radiology artificial intelligence . the clinical trials space to reduce time Namibia as part of a country-specific and Modeled ideal screening chest CT and cost of drug development . Built global strategy . interval in patients with sarcoma, and implemented new process to resulting in peer-reviewed publication, match upcoming trials with digital PricewaterhouseCoopers, international and national presenta- technologies . Executed 20+ global Los Angeles, CA tions, and research award . digital trainings, personally training Manager, Health Industries Advisory, 300 colleagues across 15+ countries . 2014-2019 University of Pennsylvania Center for Advised national health services com- Health Incentives and Behavioral L.E.K. Consulting, Boston, MA panies on growth and operational Economics, Philadelphia, PA Associate Consultant 2017–2018, strategies, including Medicare and Research Assistant, 2017-Present Associate 2015–2017 Medicaid market entry, payment Evaluate health policy effects of Partnered with clients across life sciences integrity, chronic disease management, bundled payments on health care costs and other industries on ~18 strategic and enterprise transformations . and quality, culminating in multiple and operational consulting engagements . peer-reviewed publications, national Example projects include: (1) Due presentations, and research awards . diligence on national home health provider market to inform private Access Personal Care Home & Tri-Ace equity investment (2) Strategic and Care Home Health Services, Houston, TX brand plan for $200M microbiome Consultant, 2014-Present therapeutics company (3) Revenue Advise top management of two small model and valuation to inform family-owned businesses caring for therapeutic area prioritization for elderly patients on operations, $1B early oncology biotech . finances, and growth opportunities .

17 Kenneth M. Kasper Jonathan Kern Esther S. Kim [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA University of Pennsylvania, Philadelphia, PA Princeton University, Princeton, NJ B .A ., Summa Cum Laude, Philosophy, 2015 B S. .E ,. Economics and Mechanical Engineering & A .B ., Ecology and Evolutionary Biology, 2013 Applied Mechanics, 2013 Massachusetts Institute of Technology, Cambridge, MA M .S ., Technology and Policy, 2017

Empower life sciences companies to An opportunity to design, develop and An opportunity to improve healthcare reduce human suffering through implement novel solutions that improve through strategic decision-making and innovation in science and business. healthcare. operational excellence.

Merck & Co., North Wales, PA Amazon, Remote Boston Consulting Group, Washington, DC U.S. Oncology Marketing MBA Intern, Sr. Product Manager, Summer 2020 Summer Consultant, Summer 2020 Summer 2020 Developed a machine learning partition Engaged with pharmaceutical client Developed U .S . competitive launch strat- model to block sellers infringing on on process design and operational egy for critical growth driver for leading Amazon policies, saving Amazon readiness of a spinoff entity’s R&D oncology product (Keytruda) . Developed over $50M . division . analytical approach and project plan . Managed multiple external vendors . Syapse, San Francisco, CA Aetna, New York, NY Provided input into primary market Product Manager, 2018-2019 Manager, Value-Based Solutions research design and execution . Drove Strategy Manager, 2017-2018 2017-2019 cross-functional strategic workshop, Led 3 cross-functional teams of engi- Evaluated and executed value-based including 25+ stakeholders across 9+ neers, designers, physicians and medi- care partnerships with provider groups teams . Presented strategic recommenda- cal informaticists to develop products to deliver innovative care and payment tions to U .S . oncology senior leadership . from conception to launch . Managed models for company’s growing the design, development, testing and Medicare Advantage membership . L.E.K. Consulting, San Francisco, CA launch of an analytics tool powered by Collaborated with internal stakeholders Consultant, 2019 more than 700,000 patient records for and led cross-functional teams to Senior Associate Consultant, 2018-2019 users to track non-small cell lung cancer support partnership launch . Associate Consultant, 2017-2018 molecular testing trends . Built pricing Associate, 2015-2017 and cost models for new partnerships . GE Ventures, Menlo Park, Strategy consultant dedicated to Life CA and Boston, MA Sciences practice with experience Accenture, New York, NY Healthcare Investment Associate across 30+ engagements in M&A Life Sciences Strategy Consultant, 2015-2017 2016-2017 advisory and growth strategy, advising Strategy Senior Analyst, 2014-2015 Sourced and conducted due diligence leading healthcare and life sciences Strategy Analyst, 2014 for startup investment opportunities companies . Key responsibilities Advised healthcare investment funds and across healthcare information technology, included leading project teams, con- life sciences companies on investments, services and life science tools subsectors . ducting and analyzing primary and growth strategies and operational Partnered with portfolio companies on secondary research, financial model- improvements . Conducted due diligence operational and strategic initiatives . ling, and forming and communicating and valuation analysis on over $1 .2B in strategic insights and recommendations deal value . Ran market studies which MIT Laboratory for Financial to clients . included interviewing hospital execu- Engineering, Cambridge, MA tives, physicians, payers and scientists to Graduate Research Assistant inform investment recommendations . 2015-2017 Conducted research, interviewed Vigo Technologies, Shenzhen, China industry stakeholders and published Co-Founder & COO, 2013-2014 case studies on healthcare finance Co-invented, developed and sold topics, including venture philanthropy, wearable Bluetooth headsets that academic-industry partnerships and track blink patterns and alert users early stage biotech business models . before falling asleep .

18 Michael Kim Alexander D. Robert Lou [email protected] [email protected] Washington University in St . Louis, St . Louis, MO Kondziolka Columbia University, New York, NY B .S B. .A ., Summa Cum Laude, Finance and [email protected] B .A ., Magna Cum Laude, Computer Science and Mathematics, 2015 Georgetown University, Washington, DC Mathematics, 2015 B S. .B .A ., Cum Laude, Finance and Accounting, Perelman School of Medicine at the University of 2014 Pennsylvania, Philadelphia, PA M .D . Candidate, 2021

An opportunity to improve healthcare An opportunity to build growth stage An opportunity to create and through an advising or operating role. healthcare services and life sciences commercialize products that leverage businesses through a private equity technology to improve health. Genentech, South San Francisco, CA investing role. MBA Commercial Summer Associate, Google, Mountain View, CA Summer 2020 Ampersand Capital, Wellesley, MA Product Manager Intern, Summer 2020 Led access-related initiatives for a $2B+ MBA Intern, Summer 2020 Developed product strategy for Google rare disease drug to communicate value Led market diligence for investment Cloud Security . Conducted market proposition to payers and formulary opportunity in diagnostic kit manufac- analysis to identify opportunities and committees . Developed budget impact turer, including evaluating novel bio- performed qualitative user research . model, healthcare economic video, and markers in gastroenterology . Explored field training materials by managing a impact of COVID-19 on Ampersand’s University of Pennsylvania, Department payer publication and co-creating with investment sectors and presented of Radiology, Philadelphia, PA internal product review committee and investment theses on subsectors of clin- Medical Student Researcher, 2017-2020 healthcare economic research team . ical trial logistics to investment staff . Led team of engineers, clinicians, and statisticians to develop deep learning Bain & Company, Dallas, TX TA Associates, Menlo Park, CA models to detect follow-up recommen- Consultant, 2018-2019 Associate, 2016-2019 dations in the text of radiology reports . Senior Associate Consultant, 2017-2018 Evaluated and executed investment Identified FDA-approved drug candidates Associate Consultant, 2015-2017 opportunities in healthcare businesses to be repurposed for COVID-19 treatment . Advised clients from multiple industries for $8 .5 billion growth private equity on key strategic and operational issues . fund . Led transaction sourcing efforts MathWorks, Natick, MA Performed research to determine mar- in the life sciences tools, payor services, Software Engineer, 2015-2016 ket conditions, partnered with senior managed care, PBMs, labs, and provider Developed functions for the Statistics management, and recommended busi- groups subsectors . Analyzed and con- and Machine Learning Toolbox for ness management strategies to drive ducted diligence for closed investments MATLAB . Contributed to all parts of full potential of their businesses . in a supplier for the cell and gene the development cycle, including Conducted commercial due diligences therapy supply chain and in a national design, implementation, testing, and to inform private equity investment provider of autism therapy services . deployment . Parallelized frequently decisions through a rotation in Bain’s used back-end C++ functions, which private equity group . Credit Suisse, New York, NY resulted in faster runtimes by 50% for Investment Banking Analyst, 2014-2016 the majority of users . Axcella Health, Cambridge, MA Executed M&A and financing transac- Corporate Finance & Strategy, 2017-2018 tions for the healthcare coverage Developed company valuation model group . Completed several financing by working cross-functionally with the transactions in the biopharmaceutical commercial group to value assets and and healthcare services spaces as well assess revenue potential of clinical- as the sales of a sterile compounding stage candidates and newly identified pharmacy and of an oncology-focused disease opportunities . Drove strategy device business . workshop for key executives, redefin- ing Axcella’s mission, vision, and 3-year strategy roadmap .

19 Alison S. Magruder Gabrielle B. Manoff Govind S. Mattay [email protected] [email protected] [email protected] Williams College, Williamstown, MA Brown University, Providence, RI University of Pennsylvania, Philadelphia, PA B .A ., Magna Cum Laude, Economics and B S. ., Honors, Neuroscience, 2016 B .A .S ., Summa Cum Laude, Bioengineering, 2016 Psychology, 2015 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2021

An opportunity to utilize quantitative An opportunity to bring transformative An opportunity to build and and qualitative skills to improve the therapies to patients by leading implement novel technologies quality and operational efficiency of commercial strategy or operations at to improve patient care. care delivery in hospital systems. an innovative biotechnology company. Genentech, South San Francisco, CA NewYork-Presbyterian, New York, NY Vertex Pharmaceuticals, Boston, MA Business Development Summer Associate, Graduate Intern, Summer 2020 MBA Intern, Global Marketing Pipeline, Summer 2020 Worked onsite with the Operations Summer 2020 Developed and implemented a strategy team at Weill Cornell on a variety of Owned competitive intelligence to engage with Venture Capital firms projects including supporting the research project, developing key to gain insights into early-stage bio- opening of the Alexandra Cohen insights and recommendations for technology innovations . Supported Hospital for Women and Newborns, Duchenne Muscular Dystrophy (DMD) teams of scientists, clinicians, lawyers, optimizing visitor screening processes market development . Directed DMD and finance professionals to execute considering COVID-19, coordinating US patient journey market research licensing and acquisition deals for bio- logistics and distribution of donations with external consultancy, consolidat- technology assets . to essential workers and managing ing output from 40+ patient caregiver department interns . and physician interviews to inform Clinarify, Philadelphia, PA 2021+ commercial brand strategy and Co-founder and CEO, 2020 Montefiore Health System, Bronx, NY tactics . Chaired weekly cross-functional Created a multidisciplinary expert Strategic Planning Analyst, 2017-2019 Global Commercial Team meetings for network of practicing clinicians . Constructed comprehensive market pipeline CRISPR DMD asset to establish Clinarify connects health care compa- assessments of system footprint used brand plan . nies with clinicians who provide expe- to guide leadership discussions on rience-based advice for product design strategic initiative of system align- PwC Pharmaceutical & Life Sciences R&D and clinical workflow implementation . ment . Built a dynamic quality dash- Advisory, New York, NY Helped lead team of six to recruit over board instrumental to inform senior Senior Associate Consultant, 2018-2019 200 clinicians and secure the HealthX leadership discussions . Compiled and Associate Consultant, 2016-2018 Ventures award . analyzed market, organizational and Advised biopharmaceutical companies financial data to enhance service line on R&D strategy, implemented tools University of Pennsylvania, Department strategies and projects for key opera- and processes to improve effectiveness of Radiology, Philadelphia, PA tional and executive members . of R&D operations, and enabled Medical Student Researcher, 2019-2020 organizational transformations . Project Designed and conducted studies to Morgan Stanley, New York, NY Highlights: (1) Collaborated with inter- examine the impact of novel imaging Leveraged Finance Analyst, 2015-2017 national C-suite executives to success- informatics interventions, including Supported 3 industry groups fully implement global restructuring of artificial intelligence-based image (Transportation, Energy, Global Power 200+ employee R&D organization and analysis and direct radiologist-patient & Utilities) as sole analyst on transactions manage transition of R&D operations; communication, on quality, cost, and totaling $125B, facilitating efficient (2) Assessed current-state organizational access to care . Wrote study protocols, communication within teams and with capabilities and proposed opportunities analyzed large data sets, and authored clients . Synthesized data to develop for organizational improvement for multiple publications . quantitative and qualitative views of growing biotechnology company; (3) debt capital markets and company Recommended strategy and design for TowerView Health, Philadelphia, PA financial profiles for senior colleagues a global delivery model leveraging Intern, 2015 and 2017 and developed presentation materials offshore resources for global CRO . Conducted market research to guide for clients . redesign of smart pillbox that improved medication adherence .

20 Catherine L. Kira A. Mengistu, MD Natalie R. Miller Mavroudis, M.D. [email protected] [email protected] Harvard University, Cambridge, MA University of Pennsylvania, Philadelphia, PA [email protected] B A. ., Human Evolutionary Biology, Global B .S .E ., Summa Cum Laude, Systems Science & Emory University School of Medicine, Atlanta, GA Health and Health Policy, 2011 Engineering, 2015 M .D ., Magna Cum Laude, 2016 University of North Carolina School of Boston College, Chestnut Hill, MA Medicine, Chapel Hill, NC, M .D ., 2016 B .S ,. Summa Cum Laude, Biochemistry, 2012

An opportunity to increase the value of An opportunity to leverage my clinical An opportunity to work for a mission- surgical care delivery through advance- background and entrepreneurship drive driven organization in a strategic role ments in evidence-based care distribution to improve the patient experience of care. that improves patient health while within hospitals and health systems. driving payor-provider collaboration. Viva Global Fertility Solutions, Center for Surgery and Health Economics, Philadelphia, PA Humana, Louisville, KY Department of Surgery, University of Co-founder and CEO, Summer 2020 Care Delivery MBA Intern, Summer 2020 Pennsylvania, Philadelphia, PA Co-founded Viva Global Fertility Worked with Chief Growth Officer Research Fellow, 2019-present Solutions in Summer 2020 . Conducted to expand system of Medicare value- Perform research in health system 250+ interviews with women in target based primary care centers . Set structure, cost, and outcomes for surgi- market . Structured and established a differentiation strategy for integrated, cal patients . Conducted an ongoing clear idea and value proposition, tar- senior-focused care model across 50+ multi-center longitudinal study of geting and customer sourcing strategy . new centers within $600M JV with workforce issues for surgeons during Identified, qualified and met with sev- leading PE firm . Executed innovative the Covid-19 pandemic . Completed eral top London fertility clinics as partnership with real estate trust to retrospective studies on modern gen- potential partners and reached part- launch in-home care for improved eral surgery practice and implications nership agreements . chronic disease and SDOH management . for training . Taught an innovative combined quality improvement and Hospital of the University of Boston Medical Center Health System, wellness curriculum for junior general Pennsylvania, Philadelphia, PA Boston, MA surgery residents . Internal Medicine Attending Physician, Senior Strategy Manager, 2017-2019 2019-2020 Responsible for delivery of Department of Surgery, University of Delivered emergent and life saving Accountable Care transformation to Pennsylvania, Philadelphia, PA treatment to patients in an inpatient COO across strategy and operations Resident Physician (General Surgery), and intensive care unit setting during for $3B Health System . Designed and 2016-present COVID-19 era . Supervised and taught executed account management of Led surgical teams, formulated patient clinical practice standards to physician provider partnerships (serving 200K+ care plans, and gained technical skills assistants and resident physicians . Led patients) to drive care integration and and autonomy in the operating room daily patient care coordination meetings quality . Managed medical coding ini- under the supervision of attending with cross-functional team of nurses, tiatives to improve risk adjustment surgeons . As a first- and second-year social workers and case managers . accuracy for complex patients . resident, provided direct patient care Supported integration of corporate on the floor and in the intensive care functions within BMC Hospital and unit, and worked with interdisciplinary BMC HealthNet Plan to achieve $20M teams, evaluating patients without operating savings . Led daily readmis- surgical problems throughout the sion reduction workflows to monitor hospital . Elected by peers as a patients post-hospitalization . representative to the Department of Surgery Residents’ Executive Council to McKinsey & Company, New York, NY address programs and initiatives with Senior Business Analyst, 2015-2017 leadership (Fall 2016-Spring 2019) . Advised clients on strategic and operational issues across industries, focused on healthcare as part of the Healthcare Leadership Track .

21 Megha Motgi Dan Nahum Ryan M. O’Keefe [email protected] [email protected] ryan.okeefe@[email protected] Georgetown University, Washington, D .C . Yale University, New Haven, CT The College of the Holy Cross, Worcester, MA B .S F. .S, Cum Laude, Science, Technology, and B A. ,. with Distinction, Economics, 2016 B .A ., Magna Cum Laude, Biology, 2014 International Affairs, 2014 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2021

An opportunity to work on launching An opportunity to drive change through An opportunity to utilize my business and promoting innovative drugs and investing in and partnering with market- and clinical experiences to efficiently technologies designed to improve the leading companies. finance, study and develop new patient’s quality of life and care innovative therapies for patients. experience. Tesuji Partners, New York, NY Summer Associate, Summer 2020 M3 USA Corporation, Fort Washington, PA Marketing Summer Associate Conducted fundamental equity Corporate Development Intern, Fall 2020 (Pfizer, New York, NY) research, valuation, and due diligence Created healthcare market maps with Summer 2020 to evaluate existing and potential a focus on companies innovating in Oversaw novel partnership between investments . the clinical trial research and patient vaccines business and a state recruitment spaces . Identified stand- Department of Health with the objec- MEDX Ventures, Boston, MA & out companies and pitched recommen- tive of increasing pediatric vaccina- Tel Aviv, Israel dations to management . tions in the midst of Covid-19 and Director of Business Development, 2017-2019 before school re-openings . Analyst, 2017 Biogen Inc, Cambridge, MA Structured and managed co-investment Global Product Strategy and Director, Strategic Accounts program with Fortune 500 company Commercialization Intern, Summer 2020 (Optum, Minneapolis, MN) and successfully negotiated agreements Researched, prioritized, and pitched January – June 2019 with startups representing strategic key lifecycle management ideas for Oversaw service delivery and renewals opportunities and potential revenue of the MS drug, FAMPYRA . Provided stra- of 140+ Physician Advisor Solutions cli- $1M . Increased year-over-year deal flow tegic guidance for the integration of ents in the southeast region by lever- by 140% . Conducted due-diligence on digital tools for future clinical trials aging analytics, contracting, nursing, 12+ start-ups for $1M investment each . and real-world data projects . and physician teams . Wrote PR for newspapers with 200,000 global daily readership and launched RTW Investments / Rocket Associate Director, Revenue Cycle newsletter reaching 1,000+ industry Pharmaceuticals, New York, NY Solutions (The Advisory Board Company, professionals . Analyst Intern, Summer 2016 Washington, D.C.) Analyzed the pipelines of biotech March – October 2018 EmpleApp, Tegucigalpa, Honduras companies to determine if their clinical Served on 4-person leadership commit- Co-founder and Chief Operations Officer, trials would hit their endpoints . tee focused on improving department 2016-2017 Conducted cost analyses to guide culture and performance . Managed the Established company headquarters pricing strategy of novel gene operations of third-party technology in Honduras . Hired, trained and led therapies for rare blood disorders . vendor by directing implementation of operations team of 9 employees . platform technical requests and assist- Directed business development to MGH Cancer Center, Charlestown, MA ing in developing product roadmaps . acquire large corporate clients . Research Technician, 2014-2016 Managed front-end product and Optimized a microfluidic device that Senior Consultant, Revenue Cycle San Francisco-based R&D team . isolates circulating tumor cells from Solutions (The Advisory Board Company, whole blood . Performed assays, col- Washington, D.C.) Israel Defense Forces, Israel lected and analyzed data, and helped July 2016 – March 2018 Executive Officer, 2010-2011 prepare manuscripts for publication . Served as strategic thought partner to Infantry Squad Commander, 2009-2010 executives of 10 of the department’s Infantry Soldier, 2008-2008 most valuable client portfolios ($9 4M. Led staff of 150 soldiers coming from in TCV) . Presented client case study at 20 different military corps . Organized all-revenue cycle client summit on civilian-military events and supervised $4 6M. achieved ROI in FY 2017 from on-site teams of 1000+ soldiers . clinical documentation improvement Created and executed structural initiatives . reform that cut expenses by 50% while increasing staff and client satisfaction .

22 Brandon M. Pang Liz A. Pecan Boris Pevzner [email protected] [email protected] [email protected] UCLA, Los Angeles, CA University of Pennsylvania, Philadelphia, PA Stephen M . Ross School of Business at the B .S ,. Cum Laude, Civil Engineering, 2015 B A. ., Cum Laude, Anthropology, 2015 University of Michigan, Ann Arbor, MI B .B .A ., Finance, Accounting, 2013

An opportunity to develop digital health An opportunity to leverage real world An opportunity to develop, implement products and solutions that transform the data for the improvement of therapeutic and improve value-based care strategies patient experience, improve outcomes, options and care in oncology. and solutions to better align healthcare and remove barriers to patient care. stakeholder incentives and reduce the ConcertAI, Boston, MA total cost of care. RubiconMD, New York City, NY Intern, Summer/Fall 2020 Corporate Strategy Intern, Summer 2020 Developed therapeutic guidelines for Cigna, Philadelphia, PA Led an assessment of a new market, new partnership pilot; evaluated patient Value Based Reimbursement Summer identified and planned a pilot for a $2M cohorts and outcomes analyses for Associate, Summer 2020 opportunity to expand RubiconMD’s strategic priorities in key tumor types . Conducted company-wide strategic core product beyond eConsults . Created early career research accelerator review of Cigna’s opportunity to offer Developed a market segmentation that for a company-wide initiative to reduce surgical bundled payments as a health served as a key input to the business’s cancer care disparities for patients of service product to payers; presented broader growth strategy . color and marginalized groups . findings to President of Strategy and Solutions Deloitte Consulting, San Francisco, CA Penn Center for Cancer Care Innovation, Consultant, 2018-2019 Philadelphia, PA IMC Health, Miami, FL Business Analyst, 2016-2018 Interim Manager, 2017-2019 Chief of Staff and Director of Strategic Served a wide variety of healthcare Oversaw development of the Center’s Initiatives, 2017-2019 and technology clients on projects brand, positioning, and potential pro- Reported directly to CEO . Select initia- including commercial due diligences, grams to implement inaugural year as tives: overhauled medical transportation growth strategies, billing and pay- interim manager . division to improve on-time performance ments operations improvements and from 40% to 80%; outsourced IMC’s pricing strategies . Identified $30M in Partners in Health, Mirebalais, Haiti internal diagnostics division to save net revenue opportunities by collabo- Consultant and Data Analyst, 2017–2019 business $600,000 annually . rating with hospital leadership and Developed and managed a new data subject matter experts to build a SQL program for one of Haiti’s only cancer Comvest Partners, West Palm Beach, FL pricing optimization tool . Launched clinics . Leveraged insights about the Private Equity Associate, 2015-2017 an internal knowledge sharing platform patient population to drive decision Conducted industry, financial and busi- for the Deloitte strategy community making for resource allocation . ness diligence to evaluate investments earning 6 .5k unique visits within the for $900M buyout fund . Executed first 6 months . Authored a recommen- BluePrint Research Group, New York, NY acquisition of IMC Health, a primary dation for a board of directors to Senior Associate, 2017 care physician group with 15 medical contest a $5M lawsuit after conducting Associate, 2015-2017 centers, and Lasko Products, the larg- interviews, reviewing pricing policies Led onsite team at a major biopharma est manufacturer of portable fans and and performing forensic data analysis client, providing support for commer- heaters in the U .S . to determine if pricing practices were cialization and brand strategy of pipe- aligned with industry practices . line and inline oncology brands; work RBC Capital Markets, New York, NY included discovery of up to a 15% pro- Healthcare Investment Banking Analyst, jected increase in market share for a 2013-2015 first-line immuno-oncology agent . Executed M&A and capital markets trans- Developed initial go-to-market strategy actions for healthcare services, medical with $2M budget for their first biosimi- technology and pharmaceutical clients . lar to enter the market .

23 Raphael A. Pransky Mallika Prasad Noah S. Putter [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Indian Institute of Technology, Kharagpur, India University of Michigan, Ann Arbor, MI B .A ., Magna Cum Laude, Cognitive B Tech. . and M .Tech . (Dual Degree), B .B .A ., With High Distinction, Finance, 2014 Neuroscience, 2014 Agricultural and Food Engineering, 2015

An opportunity to build and scale An opportunity to be a strategic and An opportunity to build, invest in and innovative healthcare companies that financial advisor to healthcare businesses. guide innovative, growth-stage democratize access to care and improve healthcare companies. the patient experience. J.P. Morgan, New York, NY Investment Banking Summer Associate, Varian Medical, Remote Redesign Health, New York, NY Healthcare Group, Summer 2020 MBA Intern, Strategy and Corporate New Ventures Intern, Summer 2020 Advised healthcare companies on Development, Summer 2020 Conducted in-depth concept testing M&A transactions and IPOs . Select Engaged in strategy development for for remote patient monitoring venture experiences include buy-side M&A of leading radiation oncology medtech ahead of investment committee . medical device company, drafting of and software solutions provider, Identified opportunity to disrupt S1 and confidential SEC filing for IPO including assessing emerging, software- Medicare Advantage distribution for healthcare services firm and target related market . Evaluated 2 software market and developed new venture identification for life sciences client . investment opportunities . Spearheaded proposal . Created and analyzed pro- initiative to overhaul and standardize prietary dataset of 200+ healthcare Bessemer Venture Partners, internal investment tracking process . startups to determine characteristics of Bengaluru, India successful founding teams . Pre-MBA Summer Associate, Summer 2019 CRG, New York, NY Developed India healthcare invest- Investment Associate 2016-2019 American Securities, New York, NY ment thesis . Assessed customer behav- Evaluated $20M-$200M investment Strategy Associate, 2017-2019 ior and global comparables for $15M opportunities for $4B AUM healthcare Led commercial due diligence efforts investment in personal care start-up . growth investing firm . Responsibilities for 10+ investment opportunities, con- included financial modeling, conduct- ducting extensive primary and second- DaVita, Pan-Asia ing company and industry due dili- ary research to assess market dynamics, Project Lead, APAC Operations and Growth, gence, managing third-party advisors competitive landscape, and growth 2016-2019 and presenting analysis to investment prospects . Provided investment team Chief of Staff to APAC COO . Managed committee . Completed 4 investments, with conviction to successfully pursue projects in growth and operations including largest Fund IV investment one platform investment and two add- across Malaysia, China, Singapore and to date, and supported multiple port- on acquisitions, representing over $1B India . Select projects include acquisi- folio companies . Led raising of long- in transaction value . Partnered with tion of clinics in China, negotiating term leverage at fund level through portfolio company management teams with insurers in Malaysia, and imple- asset backed securities offerings . to generate value creation plans, menting medical supplies usage track- execute strategic projects (e g. ., new ing to reduce wastage in India . Leerink Partners, New York, NY market entry), and direct commercial Investment Banking Analyst 2014-2016 initiatives (e .g ., pricing optimization) . Parthenon-EY, Mumbai, India Advised healthcare clients on M&A, Associate Consultant, 2015-2016 financing, and strategic alternatives by Oliver Wyman, New York, NY Completed a record 15 investment developing valuation analyses, perform- Senior Consultant, 2016 advisory projects in 17 months for ing due diligence and preparing Consultant, 2015 private equity clients across Brazil, offering memoranda . Deals included Advised healthcare and financial China, India and SE Asia . Select Amicus’s acquisition of Scioderm and services clients on strategic and experiences include developing India Adaptimmune’s IPO . operational issues . Negotiated brand growth strategy for pharma instrument licensing extension for national elderly supplier and commercial due diligence special interest group, performed of $1B higher education chain in Brazil . medical management diagnostic for regional health insurer, and conducted risk assessment and mitigation for global bank .

24 Christopher S. Nirali V Sampat Chris Seitz Ragsdale [email protected] [email protected] Columbia University, New York, NY Williams College, Williamstown, MA [email protected] B S. ., Biomedical Engineering, 2014 B .A ., Biology and German, 2015 Davidson College, Davidson, NC B .S ,. Environmental Studies and Medical Humanities, 2010

An opportunity to drive strategy, An opportunity to lead strategy or An opportunity to invest in and build change, and innovation at America’s operations at a pharmaceutical or transformative healthcare companies. most promising health systems, with a biotechnology company and bring focus on improving health outcomes for innovative medicines to patients Nantahala Capital, New Canaan, CT underserved populations. worldwide. Healthcare Equity Analyst, Summer 2020 Analyzed healthcare public equities for Mount Sinai Health System, New York, NY Bank of America, New York, NY a $1 .5B long/short hedge fund . Focused Boston Consulting Group (BCG) Social Summer Associate, Summer 2020 on healthcare, primarily on biotech, Impact Ambassador, Summer 2020 Conducted industry analysis and medtech, and digital health . Performed Social impact ambassador through financial modeling . Prepared due diligence, built financial models, BCG summer consultant internship valuation-focused materials for and interfaced with management on program . Managed Mount Sinai’s healthcare companies . existing investments and pitched new business development pipeline for ideas to the investment team . COVID-19 testing and advisory services . Sage Therapeutics, Boston, MA Developed go-to-market strategy for a Business Insights & Analytics, 2018 - 2019 Dorm Room Fund, Philadelphia, PA new concierge health center in West Led forecasting and analytics for the Managing Partner, 2019-2021 Village neighborhood . US commercial launch of ZULRESSOTM, Premier student led VC with $6M AUM the first FDA-approved treatment for backed by First Round Capital . As PricewaterhouseCoopers (PwC), post-partum depression . Built demand Managing Partner, manage 12 Washington DC forecasts and patient out-of-pocket Investment Partners across undergrad- Senior Associate, 2016-2019 cost models to inform launch planning . uate and graduate schools, source and Led teams to fulfill Congressional Conducted market research and evaluate deals, and manage portfolio requirements and develop 28 policy competitive analysis to inform of more than 300 companies . recommendations that sought to ZULRESSOTM positioning . increase access to healthcare and Excel Venture Management, Boston, MA human services for underserved popu- Merck KgaA, Rockland, MA Associate, 2017-2019 lations . Conducted strategic planning Business Analysis & Forecasting, 2017 - 2018 As only associate, sourced, evaluated, and stakeholder management for fed- Led forecasting and analytics for US and managed a portfolio of more than eral Cabinet-level council tasked by Fertility & Endocrinology franchise . 20 healthcare companies for $250M the White House to improve human Improved forecast accuracy to 99% healthcare venture capital fund . services for people with disabilities across 5 drug brands . Created multi- Invested over $50M in 16 companies and older adults . Executed nationwide variable profitability tool for newly across biotech, medical devices, digital marketing and education campaign to launched Fertility Technologies device health, and diagnostics in private first- reduce Medicare fraud . to inform customer pricing strategy . time and follow-on investments and IPOs . Interfaced directly with portfolio UnitedHealth Group, Washington, DC Strategic Research Insights, Princeton, NJ company CEOs, attended board meet- Research Consultant, 2014-2016 Engagement Manager, 2016 – 2017 ings, and presented to Limited Partners . Analyzed Medicaid data and con- Associate, 2014 - 2015 ducted patient and provider interviews Led 25+ market research and analytics Health Advances to identify unnecessary nursing home engagements for top 10 pharmaceutical Senior Analyst, Analyst, 2015-2017 admissions . Implemented federal pilot clients, advising new product launches, Strategy consultant to biotech, to reduce hospital readmissions, result- pipeline planning, sales force optimi- medical device, and healthcare services ing in 13% fewer readmissions than zation and marketing strategy . Served clients . Conducted due diligence, control group . Authored policy paper as primary client contact and managed formulated business strategies, and on long-term care, which is now daily workflow for junior employees . forecasted future sales . distributed as federal guidance for state governments .

25 Mosum Shah Victoria Z. Shih Benjamin H. Shuford [email protected] [email protected] [email protected] University of Chicago, Chicago, IL Harvard University, Cambridge, MA University of North Carolina, Chapel Hill, NC B .A ., General Honors, Economics, 2016 A .B ,. Magna Cum Laude in Field, Applied B .S . Business Administration, 2013 Mathematics, 2014

An opportunity to assess innovative An opportunity to modernize healthcare Drive change through investing in and technology to better collect information delivery by identifying, funding and helping build market-leading companies. from patients and support the delivery growing strong technology-enabled of care through various telemedicine healthcare businesses. LLR Partners, Philadelphia, PA offerings. MBA Investment Intern, Healthcare Private Francisco Partners, San Francisco, CA Equity, Summer 2020 Teladoc Health, New York, NY MBA Summer Intern, Summer 2020 Developed firm-wide investment thesis Product Strategy Intern, Summer 2020 Member of the private equity invest- and strategy for home healthcare Spearheaded product development of ment team . Evaluated buyout invest- services sector and evaluated an AI-based tool focused on collecting ments for a technology-focused private opportunities within the segment . deeper patient data to better inform equity firm investing out of multiple the member experience and supply funds totaling ~$10B . Conducted finan- Green Hill Recovery, Raleigh, NC providers with further patient history cial, market and micro business dili- Founder and CEO, Behavioral Healthcare and symptomatic information . Defined gence on new investment opportunities Startup, 2016-2019 key use-cases incorporating clinical input, across technology sectors . Founded behavioral healthcare identified implementation options, company to treat young adults and generated buy-in across relevant Goldman Sachs, New York, NY suffering from substance abuse and functions . Presented work to the CEO Investment Banking Analyst & Associate, other mental health issues, while and expected product launch is Q1 ‘20 . Not-for-Profit Healthcare, 2014-2019 providing access to educational and Advised some of the nation’s largest career opportunities that are seldom Boston Consulting Group, Chicago, IL and most preeminent 501(c)(3) health available at other programs . Grew Associate 2016-2018 systems on mergers & acquisitions and staff to over 15 employees before Consultant 2018-2019 partnerships across the payor / provider selling business in Spring 2019 . Performed diligence on targets for landscape; structured and executed CEO of Fortune 100 company by evalu- municipal & investment grade debt Woodson Capital, New York, NY ating and modeling revenue potential financing / refinancing transactions; Analysts, Long-Short Hedge Fund, of target drugs in key therapeutic and developed tailored risk analytics models 2015–2016 disease areas through build of patient to size multiyear capital plans, determine Performed analysis of public equity uptake, switching rates, and adherence; appropriate capital structure and evaluate investment opportunities within the efforts led to a $50B acquisition . investment policy . Built 3-statement consumer, healthcare and technology Developed a risk-based strategy for a operating models, performed valuation sectors . U .S . payer by determining physician and credit analyses, created investor incentives to support adoption of marketing materials and modeled Morgan Stanley, New York, NY value-based care for high-cost operational & balance sheet dynamics Investment Banking Analyst, Consumer Medicare Advantage patients and using statistical distributions . Worked Retail Coverage Group, 2013-2015 identified potential physician groups/ closely with health system finance & Advised consumer and retail clients on patient populations as key partners . treasury teams, C-suite management M&A, financing, and strategic alterna- and external advisors such as consul- tives by developing valuation analyses, Children’s Hospital of Philadelphia, tants and counsel . performing due diligence and prepar- Philadelphia, PA ing offering memoranda . Business Development Associate, 2018 Defined an innovative patient-centric, consumerism strategy for CHOP that included reducing wait-times by right- sizing appointments, identifying and expanding operation room utilization in satellite surgical centers to reduce time to appointments, and optimizing use of NP/MD in key medical specialties to improve access .

26 Neha Srivastava Chip H. Stine Philip S. Susser [email protected] [email protected] [email protected] Yale University, New Haven, CT University of Pennsylvania, Philadelphia, PA Cornell University, Ithaca, NY B S. ., Policy B .A ., Economics, 2014 B A. ., Cum Laude, Philosophy, Politics and Analysis and Management, 2016 Economics, 2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2021

An opportunity to work in a strategic An opportunity to build and lead An opportunity to operate at interface role to support companies improving technology-enabled healthcare businesses of clinical medicine and industry to access and quality of care through that drive better patient outcomes. drive innovation and improve advisory, investment, and business healthcare quality. development. Thrive Capital, New York, NY Research & Incubations Intern, Marinus Pharmaceuticals Philadelphia, PA Centerview Partners, New York, NY Summer 2020 Business Development MBA Intern, Investment Banking Summer Associate Performed market research and presented Summer 2020 Summer 2020 detailed thesis on a healthcare subsector Developed financial analysis to evaluate Advised pharma, biotech, and retail with four potential startup incubation company’s lead drug candidate, including companies on various strategic opportunities to the investment decision tree analysis . Selected list of transactions . Experience included due committee of a large, multi-stage two-hundred licensing opportunities diligence, valuation, development of venture capital firm . within multiple therapeutic areas management presentations, and aligning with company long term goals strategic and market assessments . Oscar Health, New York, NY and developed overall framework for Senior Manager, Network Partnerships, 2019 analyzing such opportunities . L.E.K. Consulting, Boston, MA Manager, 2018-2019 Senior Associate Consultant, 2019 Associate, 2017-2018 Clinarify Philadelphia, PA Associate Consultant, Associate 2016-2019 Managed team accountable for the Co-Founder, 2020 Managed domestic and international financial and operational performance Part of founding team of healthcare teams to conduct primary and secondary of fifteen national network vendors expert network that serves as a bridge research, model quantitative forecasts, that provided services for behavioral between clinical consultants and and provide strategic recommendations health, pharmacy, durable medical industry, helping to provide clinical to 25+ biopharma, healthcare services, equipment, labs, transplants and input to product development . Grew and private equity clients . Examples infusions . Led all expansion initiatives physician membership to 200+ physi- include senior managed care expansion across vendor portfolio during high cians across 13 specialties . Winner of strategy for Fortune 50 Healthcare growth period where Oscar doubled its Health X Venture Fund award . Company (winning firm’s 2017 Global customer base and launched two new Impact Award), profitability and cost- insurance products . Established and Neuroflow Philadelphia, PA reduction strategy for national home chaired cross-functional Behavioral Clinical Analyst, 2017 health agency, revenue forecast assess- Health Committee to develop company’s Performed market research for a mental ments, product acquisition screens, and plan for improving access to treatment health tech company by interviewing financing strategy for clinical-stage assets . and coordinating care for patients with KOL’s, driving product development . mental health needs . Collaborated with start-up team Citigroup Global Markets, New York, NY members to implement useful Analyst, 2014-2015 Aon, New York, NY go-to-market strategies and find Developed the firm’s research efforts Consultant, Strategic Advisory, 2015-2016 novel revenue streams . in the high yield credit space, developing Associate Consultant, 2012-2015 tradable credit views and published Advised F500 clients across different forecasts and investment recommen- industries and supported practice dations on 30+ companies . Advised leadership on healthcare vertical hedge funds and asset managers on research and go-to-market planning . FX derivatives pricing . Led on-site project team at client through the implementation of a private retiree health exchange platform and the development of a five-year employee wellness program strategy .

27 Samuel Tang Jonathon Thierer Craig F. Thompson [email protected] [email protected] [email protected] Princeton University, Princeton, NJ, A B. ,. Manhattan School of Music, New York, NY Middlebury College, Middlebury, VT Summa Cum Laude, Economics, 2013 B A. ,. Vocal Performance, 2015 B .A ., cum laude, Mathematics and Economics, 2014 University of Pennsylvania Law School, School of Engineering and Applied Sciences at Philadelphia, PA, J .D . Candidate, 2021 the University of Pennsylvania, Philadelphia, PA Master of Computing & Information Technology Candidate, 2021

An opportunity to invest in, partner An opportunity to help build successful An opportunity to drive change through with, and build market-leading healthcare analytics companies as a leader investing in and helping build market- healthcare companies in product development and strategy. leading companies.

New Mountain Capital, New York, NY Cedar Gate Technologies, Greenwich, CT Consolidata, Philadelphia, PA MBA Intern, Summer 2020 (Remote) Co-Founder, Summer 2020 As a member of the Private Equity Data and Analytics Intern Co-Founded enterprise software company group, conducted due diligence and Summer 2019 to help private equity-backed companies executed an investment in a dietary Developed pharmacy analytics module prepare budget forecasts more accurately, supplements business and partnered to be added to Cedar Gate Technologies’ quickly and easily . Managed all aspects with two portfolio companies in evalu- (CGT) existing risk-based analytics of building the business including ating add-on acquisition opportunities platform, ISAAC . Identified opportunities product management, business to improve pharmacy operations for development, hiring, and fundraising . The Carlyle Group, New York, NY payers and health systems worth an Backed by First Round Capital’s Dorm Private Equity Associate, 2015-2018 average $9M per client per year . Applied Room Fund, Weiss Tech House As a member of the U .S . Buyout fund’s artificial intelligence to study applications Innovation Fund and Penn Wharton Healthcare group, evaluated investment of pharmacy claims in improving Innovation Fund . opportunities and managed portfolio management of risk-based contracts . companies, including launching an KKR, New York, NY acquisition platform for pharmaceutical UnitedHealth Group (OptumRx), Private Equity Associate, 2017–2019 products, executing a take-private LBO of Chicago, Il Member of Customized Portfolio a contract manufacturer, carving out a MAC Pricing Manager 2017–2019 Solutions team . Invested $500 million diagnostics business, and restructuring a Technology Development Program Lead across eight private equity fund invest- post-acute care provider . 2016–2017 ments and six co-investments across Optimized generic pharmaceutical healthcare, technology, consumer/ J.P. Morgan, New York, NY spending of leading health plans and retail, and industrials sectors including Investment Banking Analyst, 2013-2015 employers through development and co-investments in $10 .7 billion take- As a member of the Healthcare Group, implementation of data science private acquisition of Envision (NYSE: advised companies on M&A transactions, applications . Managed annual drug EVHC) and 7 .0 billion carveout of equity and debt financings, and spend of $1 .35B, positively impacting Upfield from Unilever . strategic alternatives . OptumRx’s margin by more than $100M . Goldman Sachs, New York, NY Venture Opera, New York, NY Investment Banking Associate, 2016–2017 Founder and General Director 2014–2016 Investment Banking Analyst, 2014–2016 Founded Venture Opera to reduce Member of the Healthcare & opera industry’s dependence on Consumer Retail team . Advised top charitable contributions as a revenue healthcare services and biotech companies source . Grew annual operating budget on various transactions, including Eli from $15,000 to $500,000 and managed Lilly’s $960M acquisition of CoLucid a team of 60 professionals . Successfully Pharmaceuticals, Mylan’s $33B hostile targeted a younger demographic in an takeover bid for Perrigo and $50B+ in industry traditionally focused on the debt and equity financings . senior population .

28 Samantha Tucker Sandy Varatharajah Karl Wang [email protected] [email protected] [email protected] Washington University in St . Louis, St . Louis, MO Georgetown University, Washington, DC Tufts University, Boston, MA B .A ., Honors, Political Science and Public B S. ., Biology; Science, Technology, and B .A ., Magna Cum Laude, Quantitative Health, 2014 International Affairs, 2014 Economics, 2012

An opportunity to build and scale An opportunity to scale health equity An opportunity to build and scale healthcare delivery organizations across elderly, rural, minority, and innovative healthcare solutions that that lower cost and increase access low-income populations. meaningfully improve care delivery for patients. efficiency. Amazon Web Services, Remote DaVita, Denver, CO MBA Intern, Summer 2020 athenahealth, Boston, MA Redwoods Associate, Sumer 2020 Partnered with Data Science to create Corporate Strategy Intern, Summer 2020 Conducted 15+ hours of physician and deploy risk stratification model Designed a Tier Program for interviews to design program to more across 5,000+ customers, including athenahealth’s Marketplace Partners effectively engage physicians in dialysis hospitals, and built predictive risk (i .e . app developers) to help drive modality education for acute kidney model product roadmap . greater Partner adoption among disease patients . Identified three key Clients and monetize athenahealth’s barriers to education and developed a Maverick Ventures, Remote Marketing services . one-stop shop and modality resource MBA Intern, Spring 2020 toolkit to support physicians and Evaluated tech-enabled, value-based Reify Health, Boston, MA nurses in acute settings . Developed care companies across multiple special- Customer Success Team Manager 2018–2019 detailed roadmap and physician ties for early-stage investments . Business Development Associate— adoption plan to test program at Customer Success Lead 2016–2018 three pilot hospitals . Cityblock Health, Brooklyn, NY Hired as the sixth employee, worked Innovation & Execution Senior Associate, closely with CEO to bring Reify’s flagship Deloitte Consulting, New York, NY 2018-2019 product, StudyTeam, to market, leading Consultant, 2018–2019 Integrated decision support into care to >15% MoM user growth since Business Analyst, 2016–2018 management product to risk stratify launch . Built Reify’s new user product Worked with C-Suite executives across patients and facilitate panel management . implementation process, including payor and provider organizations to Scoped medication management ini- sales, onboarding, and user engage- grow new or existing business lines . tiatives improving quality and savings ment . Scaled Reify’s business operations Select experiences include: retail across managed Medicaid members . by building the Customer Success Team . health growth strategy development, Designed company’s first life science pharmacy benefit management launch Zocdoc, New York, NY client-facing report that provided strategy, health plan M&A deal strat- Office of the CEO; Product Commercialization insights into a clinical trial based on egy and execution, health plan mem- Associate; Implementation Lead 2016-2018 analysis of StudyTeam and client’s ber operations service model redesign, Recruited to support CEO on special clinical trial data . and global pharmaceutical compliance projects, and was the first commercial- spend analysis . Held leadership roles ization team hire . Drove go-to-market Putnam Associates, Boston, MA within NY office for Analyst / strategies for three new products . Consultant, 2015–2016 Consultant community . Helped shift business model from sub- Senior Associate Consultant, 2014–2015 scription to transaction pricing, leading Analyst – Associate Consultant, 2012–2014 Pulse Advisory, New York, NY to significant supply side growth within Managed overall project development, Venture Fellow, 2014-2015 six months of launch . formed strategic recommendations, Conducted financial due diligence and presented findings to client teams and reviewed business plans for cybersecurity The Advisory Board Company, simultaneously managed 2-3 junior startups . Efforts focused on seed stage Washington, DC team members . Project work includes through Series B startups raising Management Consultant, 2014-2016 pricing and contracting, commercial rounds or partnering with institutional Built commercialization strategy for opportunity assessment, due diligence banks and insurers . major EHR’s emerging acute care product and competitive threat analysis . to launch new business vertical . Therapeutic areas span Oncology, Rare Evaluated risk adjustment programs Diseases, Vaccines, Cardiology at health systems to optimize care delivery for Medicare beneficiaries .

29 Hannah Williams Merry Xiao Vincent J. Yeh [email protected] [email protected] [email protected] Cambridge University, UK Northwestern University, Evanston, IL University of California, Berkeley; Berkeley, CA BA (Hons), Natural Sciences (Neuroscience) 2013 B A. . Mathematical Methods in the Social B .S ., Summa Cum Laude, Chemical Queen Mary, University of London, UK Sciences (MMSS) and Economics, 2014 Engineering, 2013 MSc, Neuroscience and Translational Medicine, Kellogg Certificate for Undergraduates in Stanford University; Stanford, CA 2015 Financial Economics M .S ., Chemical Engineering, 2015

An opportunity to bring novel treatments An opportunity to drive impactful clinical An opportunity to develop innovative to patients through advancing cutting- programs that empower patients in high digital health products and drive edge science. risk populations. improved health outcomes.

Denali Therapeutics OptumCare, Eden Prairie, MN Amazon Web Services (AWS), Seattle, WA Corporate Development Summer Associate Launch Leadership Program Intern, Senior Technical Product Manager, Developed Denali’s China entry strat- Summer 2020 Summer 2020 egy, based on assessment of the evolv- Assessed effectiveness of ESRD program Defined vision, design, and user ing biotech and regulatory (managing ~1000 patients and $94M experience for new feature making environment, evaluation of different total annual cost of care) against qual- it easier for developers to analyze entry models, identification and priori- ity outcomes (admits per thousand, robotics data . Created product tisation of potential partners, and con- modality, access point) and ROI roadmap and drove alignment across sideration of different clinical (utilization avoidance, staffing costs) . business development, engineering, strategies . Supported the corporate Recommended future state ESRD pro- UX, product, and marketing . Conducted development team’s live negotiations, gram with scaled up ESRD track, and 20+ user research interviews to build including Denali’s $1B partnership additional chronic kidney disease (CKD) customer use cases, identify pain points, with Biogen . tracks to proactively identify, engage, and prioritize feature development . and offer disease mgmt . to CKD Collaborated with engineers on Genentech, Inc. patients before they reach dialysis . backend technical solution . Business Development Summer Associate Spearheaded project to expand PwC Strategy&, San Francisco, CA Stryker Corporation, Fremont, CA Genentech’s neuropathology capabilities, Senior Associate 2016–2019 Staff Design Engineer, 2019 coordinating a cross-functional team Associate 2014–2016 Senior Design Engineer, 2017–2019 from Neuroscience R&D, Pathology, Partnered with clients across healthcare Design Engineer, 2015–2017 Imaging and Partnering . Conducted a subsectors to provide advice and support Led 2 cross-functional product teams of comprehensive global brain bank land- for inorganic growth strategies . Defined 16+ engineers to develop and commer- scape review, external outreach and partnership-driven diversification strategy cially launch 2 minimally invasive brain prioritisation of brain tissue access and for regional health plan by building aneurysm treatments totaling $400M collaboration opportunities . market map of healthcare services and market potential . Identified new prod- Developed a strategic roadmap for organizations and prioritizing options uct opportunity to address unmet need neuroimmunology partnering, including through several workshops . Facilitated through surveying 64 physicians across science and investment landscaping, communications and negotiations of 13 countries . Set product vision, pitched partnership opportunity screening, joint venture between PBM and retail business case and strategy to senior and final presentations to Partnering pharmacy with combined $120B annual leadership, and secured $5M in fund- and Neuroscience leadership teams . revenue from RFP to deal close . ing . Recruited core team members, set Orchestrated post-merger transition project scope, and created develop- Dementia Discovery Fund of 900 employees from Medicaid ment roadmap; led 6-person R&D team Company Creation Associate organization to acquiring regional to build minimum viable product in 3 Contributed to building the specialist health plan by identifying and months, a record within the division . venture fund’s network and invest- coordinating dependencies within ment strategy . Conducted competitive activities to ensure consistent intelligence and scientific landscaping employee communications . projects, triaged investment opportu- nities, contributed to investment due diligence, and organised Scientific Advisory Board meetings . Managed a 500,000 compound CNS-focussed small molecule library . Drove company cre- ation projects in areas of emerging biological understanding .

30 2020 Internship Sponsors

The following organizations ELEANOR HEALTH PENN MEDICINE Provided internships for Boston, MA Philadelphia, PA Health Care Management ELI LILLY PFIZER Students in Summer, 2020. New York, NY EVERSANA New York, NY PICNIC HEALTH Kelly Zhang San Francisco, CA FACEBOOK kz2168.wg21.wharton.upenn.edu Menlo Park, CA POGO Columbia University, New York, NY 7WIRE VENTURES Chicago, IL New York, NY (remote) B .S ., Magna Cum Laude, Chemical FRANCISCO PARTNERS Engineering, 2014 ACCOLADE San Francisco, CA PRINCO Philadelphia, PA Princeton, NJ GENENTECH SF ADITUM BIO San Francisco, CA REDESIGN HEALTH NY, NY & San Francisco, New York, NY (remote) CA GENENTECH / DENALI RUBICONMD AMAZON San Fransisco, CA New York, NY An opportunity to grow healthcare Seattle, WA & Remote businesses and improve outcomes GOOGLE SANOFI through an investing role. AMPERSAND CAPITAL Mountain View, CA Boston, MA Boston, MA Pogo Technologies, New York, NY HUMANA SHIKANI MEDICAL Strategy & Partnerships, Summer 2019 ARTERYS Louisville (Remote) Philadelphia, PA Led partnership development for San Francisco (remote) consumer-tech start-up by onboarding JP MORGAN SIBI HEALTH (STARTUP) 125+ online brands to power consumer ATHENAHEALTH New York, NY Philadelphia, PA & New rewards . Assisted in landing page tests Boston, MA (remote) York, NY and conducted primary research to LEE EQUITY PARTNERS evaluate various product features and BANK OF AMERICA New York, NY SOUND TELEMEDICINE value propositions . Performed New York, NY Remote competitive landscape by scraping LLR STANFORD MEDICINE thousands of competitor reviews . BCG Philadelphia, PA Palo Alto, CA Seattle, WA, NJ, MARINUS PHARMA H.I.G. Capital, New York, NY Washington, D .C . Associate, 2016–2019 Philadelphia, PA TELADOC New York, NY Evaluated investment opportunities BIND MAVERICK VENTURES across healthcare, consumer, industrials Virtual TESUJI PARTNERS and services businesses by conducting San Francisco, CA New York, NY business, financial and industry diligence . BIOGEN MCKINSEY Transaction experience includes take- Cambridge, MA Chicago, IL and San THRIVE CAPITAL private of NCI, a federal IT services Francisco, CA New York, NY provider, sale of Surgery Partners to CEDAR GATE Chicago, IL & Greenwich Bain Capital and sale of international MERCK UCLA HEALTH CT restaurant franchise . Supported Soleo Philadelphia, PA Los Angeles, CA Health, a specialty infusion pharmacy, CENTERVIEW PARTNERS by performing business analyses, MORGAN STANLEY VARIAN MEDICAL New York, NY attending board meetings, assisting London San Francisco, CA refinancings and evaluating M&A CIGNA opportunities . MT. SINAI HEALTH PARTNERS VERTEX Philadelphia, PA Boston, MA Credit Suisse, New York, NY NANTAHALA CAPITAL CONCERTO HEALTHAI Investment Banking Analyst, 2014–2016 MGMT VETERAN AND FIRST Remote Advised healthcare clients on M&A, New Canaan, CT RESPONDER New York, NY (remote) financing, and strategic alternatives, CONSOLIDATA (STARTUP) executing 2 equity offerings, 4 debt NEWYORK-PRESBYTERIAN New York W HEALTH VENTURES financings, 2 buy-side and 1 sell-side Philadelphia, PA transactions . Notable transactions Boston, MA (Remote) OPTUM OLE include advising Anthem on its CREDIT SUISSE Remote acquisition of Cigna and IPC Healthcare New York, NY on its sale to Team Health . OPTUMCARE DAVITA Minneapolis, MN Denver, CO PEAR VC DEFINE VENTURES Palo Alto, CA San Francisco, CA

31 2020 Health Care Program Mentors

Mentors are leaders and senior managers in DUSTIN CHANG ANDREW GOBERSTEIN the health care field who have agreed to Analyst Vice President Balyasny Asset Management Thomas H . Lee Partners provide career and professional development New York, NY Boston, MA advice and guidance to Health Care BRIAN CHOI GARY L GOTTLIEB, MD management students Chief Medical Information Officer; Professor Professor of Psychiatry of Medicine & Radiology Harvard Medical School George Washington University Boston, MA Washington, D .C . JEFF GREENBERG SUSAN ADLER BRETT CHUNG Founder and COO Manager Head of Product Firefly Health Sanofi Genzyme RDMD Boston, MA Cambridge, MA HUGH COLE JOHN HARROFF EUGENE AN Chief Business Officer and Head of Principal Marketing Director Corporate Development H .I .G . Capital Genentech Jounce Therapeutics New York, NY South San Francisco, CA Cambridge, MA LINDSAY HERMAN HEATHER ASPRAS SIDDARTH DAMANIA Chief Administrative Officer, Pediatrics Long Term Strategy Lead, Lung Cancer Business Development & Strategy UCLA Health Marketing Medtronic; Renal Care Solutions Los Angeles, CA Merck Nashville, TN Philadelphia, PA JANE HERZECA TOM DAVIS VP, Medicaid Program DAVID BAIADA Independent Consultant Quartet CEO Atlanta Georgia New York, NY BAYADA Home Health Care Philadelphia, PA PITAMBER “PITOU” DEVGON BRIAN HOLZER Chief Medical Officer, Co-Founder President, Kindred Innovations JOHN BARKETT Velano Vascular, Inc . Kindred Healthcare Senior Director of Policy Affairs Philadelphia, PA Louisville, KY Willis Towers Watson Arlington, VA BRANDON EINSTEIN YANG HU Principal Global Health Fellow NICHOLAS BARTZ Enhanced Healthcare Partners Bill and Melinda Gates Foundation Vice President, Business Intelligence New York, NY Seattle, WA Aledade Washintgon, D .C DANIEL FAGA MUDIT K. JAIN COO General Partner SIMON BASSEYN Mirati Therapeutics Strategic Healthcare Investment Partners Biotech Analyst San Francisco, CA Santa Clara, CA Ghost Tree Capital New York, NY MELANIE FAN SHUBHRA JAIN VP Investor JAMIL M. BEG Ampersand Capital Partners Cota Capital Principal Wellesley, MA San Francisco, CA 5AM Ventures Boston, MA MING FANG DAN KENNEDY Redmile Group Senior Director, Corporate Development ALI BEHBAHANI San Francisco, CA Kyruus General Partner Boston, MA NEA BRENTON FARGNOLI Chevy Chase, Maryland Partner LORENCE KIM AlleyCorp CFO GRACE BELL New York, NY Moderna Inc Director of Strategic Initiatives & Speciality Cambridge, MA Operations JENNIE FUNK CareMore Health/Anthem, Inc Division Vice President MICHAEL KOBY Los Angeles, CA DaVita, Inc . Co-Founder & Partner Seattle, WA 1315 Capital DARREN BLACK Philadelphia, PA Managing Director Summit Partners Boston, MA

32 RICHARD LEE GIULIA PETERLONGO DAVID SHUPPAN Associate Professor Director, Strategy Operations Senior Partner Weill Cornell Medical College DaVita, Inc . The Vistria Group New York, NY Denver, CO Chicago, IL

JOSH MAGID CHRISTIAN PENA BRET TENENHAUS Associate Regional Operations Director Vice President Evercore DaVita; Virtu Behavioral Health & Dental Great Point Partners New York, NY Mgmt Group New York, NY Irvine, CA GEOFF MEYERSON MAYA TSUKERNIK CEO and Co-Founder CARY PFEFFER Sr . Director, Data Science Strat . & Ops ,. Locust Walk Partner R&D, Janssen-JnJ Boston, MA Third Rock Ventures Boston, MA DHRUV VASISHTHA SACHIYO MINEGISHI Sr . Product Manager VP, Lead for Gene Therapies to treat Sickle AMIKA PORWAL PatientPing Cell Disease Health Care Knowledge Expert Boston, MA Bluebird Bio Boston Consulting Group Somerville, MA Chicago, IL MO YANG Vice President REGAN MURPHY ESTHER RAJAVELU GI Partners VP of Managed Care Equities Research Analyst San Francisco, CA Oak Street Health Oppenheimer & Company, Inc . Chicago, IL New York, NY BERNIE ZIPPRICH Venture Lead SHAUNAK PARIKH JON MICHAEL REESE Redesign Health Partner Vice President New York . NY EW Healthcare Partners General Atlantic New York, NY New York, NY

Administration

ERIKA H. JAMES, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

GUY DAVID, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CAROLINE SAVOIE Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

33 Faculty

The Program Faculty are drawn from BENJAMIN DORANZ, PH.D., M.B.A. JUNE M. KINNEY, M.A. the Wharton School, the School of President and CEO, Integral Molecular Associate Director, Graduate Program in Senior Fellow, Health Care Management, Health Care Management; Medicine, the School of Nursing, and The Wharton School Lecturer, Health Care Management, the School of Arts and Sciences at the The Wharton School EZEKIEL J. EMANUEL, M.D., PH.D. University of Pennsylvania and leading Diane v .S . Levy and Robert M .Levy GARY J. KURTZMAN, M.D. health institutions in Philadelphia. University Professor and Vice Provost for Vice President, Life Sciences, Safeguard Additional support is provided by the Global Initiatives; Scientifics; Lecturer, Health Care Professor, Health Care Management, Management, The Wharton School Fellows and Associates of the Leonard The Wharton School Davis Institute of Health Economics. RISA LAVIZZO-MOUREY, M.D., M.B.A BRADLEY M. FLUEGEL PIK Professor of Population Health and Senior VP & Chief Strategy Officer, Health Equity Perelman School of Walgreens; Lecturer, Health Care Medicine, School of Nursing and The Management, The Wharton School Wharton School University of ABBY E. ALPERT, PH.D. Pennsylvania Assistant Professor, THOMAS N. GILMORE, M.ARCH. Health Care Management, Vice President, The Center for Applied CLAUDIO LUCARELLI, PH.D. The Wharton School Research Inc .;Senior Fellow, Health Care Associate Professor, Health Care Management, The Wharton School Management, The Wharton School EUGENIO ANESSI, PH.D. Professor, Public Management, JOHN P. GLASER, PH.D. JEFFREY P. LIBSON, J.D. Bocconi University Graduate School of Senior Vice President, Client Partner, Cooley; Lecturer, Health Care Management, Milan, Italy; Administration, Cerner Corporation; Management, The Wharton School Lecturer and Senior Fellow, Health Care Lecturer, Health Care Management Management, The Wharton School HARI MAHADEVAN, PH.D. The Wharton School Independent Consultant; Lecturer and HENRY A. GLICK, PH.D. Senior Fellow, Health Care Management, DAVID A. ASCH, M.D., M.B.A. Professor of Medicine, Perelman School The Wharton School Executive Director, of Medicine at the University of Penn Medicine Center for Health Care Pennsylvania; Professor, Health Care INGRID NEMBHARD, PH.D., M.S. Innovation; Management, Fishman Family President’s Distinguished Professor of Medicine, Perelman School The Wharton School Associate Professor, Health Care of Medicine at the University of Management,The Wharton School Pennsylvania; MATTHEW R. GRENNAN, PH.D. Professor, Health Care Management, Assistant Professor, Health Care STEVEN A. NICHTBERGER, M.D. The Wharton School Management, Adjunct Professor and Senior Fellow, The Wharton School Health Care Management, THOMAS E. BAKER, The Wharton School J .D .William Maul Measey Professor of ATUL GUPTA, PH.D. Law and Health Sciences, University of Assistant Professor, Health Care ALEXANDER OLSSEN Pennsylvania Law School; Management, Assistant Professor, Health Care Professor of Health Care Management, The Wharton School Management, The Wharton School The Wharton School SCOTT E. HARRINGTON, PH.D. MITESH S. PATEL, M.D. LAWTON R. BURNS, PH.D., M.B.A. Alan B . Miller Professor of Health Care Assistant Professor of Medicine, Perelman James Joo-Jin Kim Professor of Health Management and Business Economics School of Medicine at the University of Care Management, The Wharton School; and Public Policy, The Wharton School Pennsylvania School of Medicine; Faculty Co-Director, Roy and Diana Assistant Professor of Health Care Vagelos Program In Life Sciences & JOHN C. HERSHEY, PH.D. Management, Management Anheuser-Busch Professor Emeritusof The Wharton School Management Science; and Health Care PATRICIA M. DANZON, PH.D. Management, The Wharton School MARK V. PAULY, PH.D. Celia Z . Moh Professor Emeritus of John M . and Thomas L . Bendheim Health Care Management, JOHN KIMBERLY, PH.D. Professor; Professor, Health Care The Wharton School Henry Bower Professor Emeritus, Health Management, Business Economics and Care Management, The Wharton School Public Policy, The Wharton School; GUY DAVID, PH.D. Professor, Economics, College of Arts and Chair, Health Care Management Sciences Department, and Director, Health Care Management Program, The Wharton WILLIAM P. PIERSKALLA, PH.D. School; Professor Emeritus Gilbert and Shelley Harrison Associate Professor, Health Care Management, The Wharton School

34 DOUGLAS A. PRESENT, M.B.A. RACHEL M. WERNER, M.D., PH.D Investor and Advisor; Associate Professor of Medicine, Lecturer, Health Care Management, Perelman School of Medicine at the The Wharton School University of Pennsylvania School of Medicine; ARNOLD J. ROSOFF, J.D. Associate Professor and Senior Fellow, Professor Emeritus, Legal Studies and Operations and Information Business Ethics; Management, Health Care Management, Lecturer, Health Care Management, The Wharton School The Wharton School JOHN J. WHITMAN, M.B.A. STEPHEN M. SAMMUT Executive Director, The TRECS Institute; Lecturer and Senior Fellow, Lecturer, Health Care Management, Health Care Management, The Wharton School Lecturer, Entrepreneurial Programs, The Wharton School SANKEY V. WILLIAMS, M.D. Professor of General Internal Medicine; CYNTHIA SCALZI, M.N., PH.D. Professor, Health Care Management, Professor Emeritus of Nursing and Health The Wharton School Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, Perelman School of Medicine at the The University of Pennsylvania University of Pennsylvania; values diversity and seeks talented Professor, Health Care Management, students, faculty and staff from diverse The Wharton School backgrounds . The University of Pennsylvania does not discriminate JEFFREY A. SOLOMON, M.D., M.B.A. on the basis of race, sex, sexual Founding Partner, Infiniti Medical LLC; orientation, gender identity, religion, Lecturer, Health Care Management, color, national or ethnic origin, age, The Wharton School JUNE KINNEY disability, or status as a Vietnam Era Associate Director, MBA Program Veteran or disabled veteran in the KEVIN G.M. VOLPP, M.D., PH.D. in Health Care Management administration of educational policies, Director, Center for Health Incentives The Wharton School programs or activities; admissions and Behavioral Economics, policies; scholarship and loan awards; Leonard Davis Institute; athletic, or other University adminis- Professor of Medicine, tered programs or employment . Perelman School of Medicine at the University of Pennsylvania; Questions or complaints regarding Professor, Health Care Management, this policy should be directed to: The Wharton School Executive Director, Office of Affirmative Action and Equal Opportunity Programs Sansom Place East 3600 Chestnut Street, Suite 228 Philadelphia, PA 19104-6106 215 .898 .6993 (Voice) 215 .898 .7803 (TDD)

©2020, The Trustees of the University of Pennsylvania . All rights reserved .

GUY DAVID, PH.D. Chair, Health Care Management Department, and Director, Health Care Management Program, The Wharton School; Photography of students: adamgierkephotography.com Gilbert and Shelley Harrison Associate Professor, Health Care Management, The Wharton School

35 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 https://hcmg .wharton .upenn .edu